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Asymmetric metabolism by sibling lymphocytes coupling  




After naïve lymphocytes are activated by foreign antigens, they yield cellular progeny with 
diverse functions, including memory cells, effector cells, and precursors of germinal center B 
cells. However, it remains unclear whether a naïve lymphocyte is capable of generating daughter 
cells with multiple fates or multiple naive cells are activated and each give rise to daughter cells 
with different cell fates. This dissertation analyzes the role of asymmetric cell division in the 
generation of effector lymphocytes and maintenance of progenitor cells. Our data provide 
evidence that daughter cells exhibit differential mitochondrial stasis and inherit different 
amounts of glucose transporters, which is coupled to distinct metabolic and transcriptional 
program in the sibling cells. 
        To uncover the links between mitochondrial st sis, transcription network reprogramming 
and cell fate, we perturbed mitochondrial clearance with pharmacological and genetic 
approaches. I found that the treatments, which impaired mitochondrial function, increased the 
differentiation of B cells and T cells into effector subsets. Thus, we hypothesize that 
mitochondrial stasis could be a trigger for effector cell differentiation. To further explore the 
mechanism for aged mitochondria-induced shifts in tra scriptional and metabolic programs, we 
used ROS scavengers and glycolysis inhibitors to demonstrate that mitochondria function and the 
  
expressions of lineage-specific transcription factors crosstalk through ROS-mediated signaling 
and activating AMPK. ROS scavenger treatments helped to maintain the progenitor population 
and suppressed the differentiation of effector subsets, whereas effector cell differentiation was 
boosted in the AMPK-α1 knockout. These results suggest mitochondrial stres -induced ROS is 
required for repressing Pax5 and increasing IRF4. 
       In addition to showing mitochondrial stasis’ connection to cell fate, this dissertation also 
demonstrates the linkage between phosphatidylinositol-3-kinases and glucose transporter 1 
(Glut1) in establishing polarity in dividing cells and in transcriptional reprogramming. The 
PI3K/mTORC1 pathway is required for maintenance of sur ace and intracellular Glut1 levels. By 
using retroviral reporters and Myc-Tagged Glut1 transgenic mice, we found that activated B cells 
and CD8+ T cells up-regulate surface and intracellular Glut1 while shifting their transcriptional 
programs toward effector cell differentiation. PI3K and Rab11a are required to establish the 
polarity of Glut1 near MOTC in interphase through metaphase, and to asymmetrically segregate 
Glut1 into the two daughter cells, suggesting that PI3K signaling not only induces the different 
transcriptional programs in the daughter cells but also establishes the self-amplifying mechanism 
of aerobic glycolysis in the daughter cell that will become an effector cell. 
 In sum, this dissertation suggests that asymmetric mitochondrial stasis and nutrient up-take 
could be part of the driving force of cell fate owing to self-reinforcement and reciprocal 
inhibition between anabolism and catabolism. These r ults shed light on the deterministic 
mechanism of effector cell differentiation and provide clues to the basis of maintenance of self-
renewal by activated lymphocytes. These findings could be beneficial for producing memory 
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Chapter 1: Introduction 
1.1 Models for generating effector and memory cell heterogeneity  
Two opposing models have been proposed to explain how lymphocytes generate robust 
effector-memory responses. The “one cell–one fate” model predicts that early stimulation 
specifies a homogeneous fate among the cellular progeny of an antigen-specific cell, whereas the 
“one cell–multiple fates” model predicts that the cellular progeny of an antigen-specific cell can 
adopt different fates. We have observed asymmetric segregation of fate determinant transcription 
factors, such as T-bet and Bcl-6, in B cells and T cells. If asymmetric division can generate 
progenies with different fates, our results will strengthen the one cell-multiple fate model. 
Visualizing the process of differentiation in vivo can, therefore, help to resolve this controversial 
issue. Here, I would like to combine multi-fluorescnt transgenic mouse model, confocal 
microscopic analysis, and intravital imaging to determine where, when, and how pre-GC B cells 
become committed to a specific fate. 
 
1.2 B cell maturation and differentiation  
1.2.1 B cell development in the bone marrow 
    The development of B cells can be divided into tw repertoires based on genetic modification 
events and where the event take place (Sagaert, Sprangers, & De Wolf-Peeters, 2007). A primary 
B-cell repertoire is derived from the hematopoietic s em cells (HSCs) in the bone marrow. HSCs 
differentiate into hematopoietic multipotential progenitors, which are the precursor of lymphoid-
primed multipotential progenitors (LMPPs) (Adolfsson et al., 2005). LMPPs have the potential 
to become monocytes and common lymphoid progenitors (CLPs). The branch point of B cell and 
T cell developments starts from CLPs, which can give r se to both B cells and T cells but not 
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myeloid-lineage cells (Kondo, Weissman, & Akashi, 1997). The development of B-cell 
precursors is guided by cytokines secreted by different bone-marrow cells, the surface receptor 
repertoire dynamics, and the coordination of several transcription factors, such as Pax5, forkhead 
box O1(Foxo1), PU.1, E2A, and early B-cell factor 1 (Ebf1) (Y. C. Lin et al., 2010). 
     However, not until the up-regulation of Pax5 epression do pro-B cells become lymphoid or 
myeloid lineage committed. Indeed, pro-B cells deriv d from Pax5 knockout mice were capable 
of differentiating into macrophages, dendritic cells, or natural killer cells with the proper 
cytokine inductions, suggesting pro-B cells are not committed to B cell lineages in the absence of 
Pax5 (Nutt, Heavey, Rolink, & Busslinger, 1999). In the next section, we will discuss their 
function and how their interaction with other transcription factors directs and maintains B cell 
commitment.  
     Immunoglobulin (Ig) gene rearrangement is the major genetic event during differentiation 
stages in bone marrow. Progenitor B-cells rearrange Ig heavy chain genes to become pre-B cells, 
which then rearrange their Ig light chain genes to become immature B-cells (Hardy, Carmack, 
Shinton, Kemp, & Hayakawa, 1991). Immature B cells are capable of expressing functional B-
cell receptors in IgM isotype, whereas mature B cells carry two receptor isotypes, namely IgM 
and IgD (Geisberger, Lamers, & Achatz, 2006; Pernis, Chiappino, & Rowe, 1966; Rowe, Hug, 
Forni, & Pernis, 1973).  
     To ensure proper rearrangement of both heavy and light chains of B cell receptors, and to 
prevent further rearrangement during cell proliferation, B cell development involves sequential 
cell proliferation and cell differentiation events. The alternating expression of different receptors 
is regulated by activating PI3K-mediated cell cycle program and negative feedback circuits that 
antagonize PI3K signals. 
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       Flt3 is highly expressed on LMPPs but lost by he late pro-B cell stage (Wasserman, Li, & 
Hardy, 1995). This is because Pax5 starts to be expressed in the pro-B cells and to suppress Flt3 
(Holmes, Carotta, Corcoran, & Nutt, 2006). CLPs canbe sub-divided into two populations based 
on the expression of lymphocyte antigen 6 complex, locus D (Ly6D). In Ly6D− CLPs, E2A and 
HEB activate the expression of Foxo1, which then cooperate with E2A and IL7 receptor signals 
to induce the expression of Ebf1 in Ly6D+ CLPs (Welinder et al., 2011). The Ly6D- CLPs are 
called all-lymphoid progenitors, which are biased toward differentiation into B and T cells but 
still can produce small numbers of NK cells or dendritic cells. By contrast, the Ly6D+ CLPs only 
generate B cells, and thus they are known as B cell biased lymphoid progenitors (Inlay et al., 
2009). In CLPs co-expressing Flt3 and IL7R, the binding of Flt3 ligand to Flt3 receptor signals 
through the ERK and AKT pathways, whereas IL7R signals through STAT5 (Ahsberg et al., 
2010; Kikuchi, Lai, Hsu, & Kondo, 2005).  
      In pro-B cells, establishment of a positive fe dback circuit composed of FoxO1 and Ebf1 
promotes B-cell development into pre-B cells. The expr ssion of FoxO1 strengthens the 
expression of Ebf1, and vice versa (Mansson et al., 2012). ChIPseq data reveals FoxO1 and Ebf1 
binds to different enhancer region of Pax5 and work c operatively to enhance Pax5, Igll1, and 
Rag1 expression. These genes are important for rearrangement of immunoglobulin heavy chain 
and assembling of pre-BCR, and thus are essential for pro-B cells to become pre-B cells. 
       Pre-B cells express IL7R and pre-BCR, which is compsed of a successfully rearranged 
immunoglobulin heavy chain and a heterodimeric surrogate light chain. The IL7R signals 
through the STAT5 and PI3K/AKT pathways to stimulate cell proliferation and to inhibit Igκ 
gene recombination, whereas the pre-BCR signals throug  Syk kinases and B cell linker protein 
(BLNK) to facilitate immunoglobulin light chain gen rearrangement and through 
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Ras/extracellular signal-regulated kinase (ERK) to inhibit cyclin D3-controled cell proliferation. 
Therefore, there are a series of feedforward and fee back regulatory loops downstream the two 
receptors to ensure one of the two receptors become at a given time. The STAT5 activates cell 
cycle and pro-survival genes by inducing the expression of cyclin D3 and by pro-survival factor 
myeloid cell leukaemia sequence 1 and B cell lymphoma 2, respectively (Cooper et al., 2006; 
Malin et al., 2010). 
       To become immature B cells, pre-B cells need to successfully rearrange their 
immunoglobulin light chain gene, which again requires the expression of Rag1/Rag2 genes. This 
event requires attenuation of IL7R signals through reduction of PI3K/AKT activity and 
enhancement of FoxO1 expression, enabling FoxO1 to enter the nucleus (Ochiai et al., 2012). In 
the pre-B cell stage, FoxO1 has been found to bind to the regulatory region of a wide range of 
genes involved in immunoglobulin recombination such as Rag1 and Rag2, cell-cycle inhibitors 
(Cdkn1a and Cdkn1b), and adaptor proteins downstream of pre-BCR signaling (Blnk and Syk) 
(Ochiai et al., 2012). By activating Blnk (also known as SLP-65) and Syk, stimulated pre-BCRs 
up-regulate the expression of IRF4 and p38 (Ishiai et l., 1999; Thompson et al., 2007).  
     The augmented IRF4 expression then stimulates the expression of chemokine receptor 
CXCR4, which directs the pre-B cells toward the chemokine CXCL12 and away from IL7-
producing stroma cells, which may serve as a mechanism for attenuating the IL7 receptor 
signaling pathway (Johnson et al., 2008). IRF4 exprssion also increases Igk and Igλ germline 
transcripts as well as Rag1 and Rag2 gene transcripts. Therefore, the expression of IRF4 induced 
by pre-BCR signaling promotes the immunoglobulin light-chain recombination in pre-B cells 
(Johnson et al., 2008). Unlike AKT-mediated phosphorylation on FoxO1, p38 activates FoxO1’s 
transcriptional activity by phosphorylation (Asada et al., 2007). In sum, FoxO1 and Pax5 
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cooperatively promote a positive feedback loop, including Blnk, IRF4 and p38, to antagonize the 
repression effect of the PI3K/AKT pathways on immunoglobulin light-chain recombination and 
inactivation of Foxo1 and thus facilitate the transition of pre-B cell to immature B cells. 
 
1.2.2 Extra follicular plasma cell and germinal center B cell differentiation 
    During development, immature B cells are trapped in the bone marrow under the guidance of 
their CXCR4 and chemokine stromal-derived factor-1 (also known as CXCL12), which is 
expressed by immature osteoblasts and endothelial cls (Ponomaryov et al., 2000). Thus, 
immature B cells egress from bone marrow is regulated by CXCR4 down-regulation (Beck, 
Gomes, Cyster, & Pereira, 2014). After immature B cells leave the bone marrow and enter the 
bloodstream, they are delivered to peripheral lymphoid organs in which a secondary B-cell 
repertoire develops. Naïve B cells are defined as the B cells that have left the bone marrow but 
not yet experienced external antigens (Banchereau, Briere, Liu, & Rousset, 1994). After 
exposure to foreign antigens, mature, naïve B cellsacquire diverse cellular fates. Activated B 
cells start to express C-C chemokine receptor type 7 and migrate to the border of T-cell zone 
(Forster et al., 1999). Some of them proliferate and differentiate into short-lived plasma cells 
secreting low affinity antibodies in the extra-follicular region (MacLennan et al., 2003; Smith, 
Hewitson, Nossal, & Tarlinton, 1996). Others migrate back into the primary B cell follicles and 
become GC B cells, which give rise to memory B cells and long-lived plasma cells secreting 
high affinity antibodies (Nossal, 1992). 
     My study focused on understanding the molecular mechanism balancing the memory and 
effector cell repertories during mature B cell differentiation. In the next section, I will discuss the




1.2.3 Transcription factors that determine memory B cell and plasma cell differentiation 
The Pax5 gene encodes a member of the paired box family of transcription factors. Pax5 is 
also called B-cell specific activator protein, because it is a mammalian homolog of the tissue-
specific activator protein in sea urchins (Barberis, Widenhorn, Vitelli, & Busslinger, 1990). Pax5 
is a key transcription factor required in early differentiation of B cells including progression 
beyond the pro-B-cell stage and repression of B-lineage-inappropriate genes (Nutt et al., 1999). 
Thus, B cell identity is maintained by expression of Pax5 throughout immature and mature B cell 
stages, until their terminal differentiation into antibody-secreting plasma cells (Delogu et al., 
2006; Nera et al., 2006).  In Pax5 knockout mice, B-cell development is blocked at the pre-B cell 
stage (Rolink, Schaniel, Bruno, & Melchers, 2002). 
The IRF4 gene encodes a transcription factor of interferon regulatory factor (IRF) 
superfamily. In accordance with its name, IRF4 is an important regulator in defending against 
viral infection (D. Xu, Zhao, Del Valle, Miklossy, & Zhang, 2008). However, IRF4 also 
modulates the development of several adoptive immune cells. IRF4 expression in both B cells 
and T cells is required for the formation of germinal center and follicular helper T cells (Willis et 
al., 2014). Furthermore, germinal center B cells and memory cells derived from IRF4 conditional 
knockout mice failed to differentiate into plasma cells, implying IRF4 is a key transcription 
factor of B cell commitment into plasma cells (Klein et al., 2006). IRF4-deficient B cells also 
lack class-switch recombination and expression of activ tion-induced deaminase (Klein et al., 
2006).  
     The relationship between Pax5 and IRF4 is complex and differs in each differentiation stage. 
In the precursors of germinal center B cells or naïve B cells that have been stimulated in vitro, 
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IRF4 expression is low and Pax5 expression is high (Shukla & Lu, 2014). Thus, IRF4 interacts 
with Ets and AP-1 family transcription factors to bind the EICE/AICE motifs on the promoters 
of Bcl6, Obf1 and AID genes (Brass, Zhu, & Singh, 1999; Glasmacher et al., 2012; Ochiai et al., 
2013). The co-expression of Bcl6 and Pax5 then stimulates the expression of AID and UNG, 
which are required for somatic hyper-mutation and class switch recombination, initiating the 
germinal center reaction (Alinikula, Nera, Junttila, & Lassila, 2011). At these early stages, Pax5 
and IRF4 have synergistic function on activated B cells. The levels of IRF4 gradually augment as 
the B cells undergo several rounds of division. 
     However, when B cells undergo terminal differentiation into plasma cells, the high level IRF4 
is required for down-regulation of Pax5, leading to the expression of plasma cell specific 
transcription factors, such as XBP1 and Blimp-1 (Jourdan et al., 2009; Shaffer et al., 2004). In 
the light zone of the germinal center, antigen presented by follicular dendritic cells and follicular 
helper T cells increases the expression level of IRF4 in centrocytes. At the higher cellular 
concentration, IRF4 can bind to the low affinity ISRE motifs. This shift in binding pattern allows 
IRF4 to stimulate the expression of Blimp-1, which represses Bcl-6 and Pax5 expression and 
initiates plasma cell differentiation (Klein et al., 2006; K. I. Lin, Angelin-Duclos, Kuo, & 
Calame, 2002).  
 
1.2.4 The regulators of Pax5 and IRF4 during B cell activation 
      In the previous section, we talked about the dynamics of Pax5 and IRF4 expression during B 
cell maturation and differentiation. Here, we are goin  to further discuss the regulators and signal 
pathways that modulate the expression of Pax5 and IRF4. The most important signaling pathway 
associated with immune cell activation is the PI3K/A T/mTOR pathway.  
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      Phosphoinositide 3-kinase (PI3K) can be activted by several kinds of receptors, including 
integrins, receptor tyrosine kinases, B and T cell receptors, cytokine receptors and G-protein-
coupled receptors (Okkenhaug & Vanhaesebroeck, 2003). In B cells, cross-linking B-cell antigen 
receptors leads to CD19 phosphorylation, which provides a docking site for class IA PI3K 
(Koyasu, 2003; Otero, Omori, & Rickert, 2001). The class IA PI3K phosphorylates the 3’-
hydroxol group in phosphatidylinositol and phosphoinositides to produce phosphatidylinositol 3-
phosphate (PI(3)P), phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2), and 
phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3 (Okkenhaug, 2013) at the plasma 
membrane. PI(3)Ps serve as docking sites for the Pleckstrin Homology domain (PH domain)-
containing protein kinases: 3-phosphoinositide dependent protein kinase-1 (PDK1) and the 
serine/threonine kinase AKT (also called protein kiase B) (Bayascas et al., 2008; Franke, 
Kaplan, Cantley, & Toker, 1997). The co-localization f PDK1 and AKT enables PDK1 to 
phosphorylate and to activate AKT (Alessi et al., 1997).  
     AKT activates mTORC1 through multiple parallel mechanisms. AKT phosphorylates 
tuberous sclerosis protein 2 (TSC2) and proline-rich Akt substrate of 40 kDa (PRAS40), which 
are negative regulators of mTORC1 function. The phos rylated TSC2 switches its partner 
from TSC1 to cytosolic anchoring protein 14-3-3, disrupting the TSC1/TSC2 dimer, which 
inhibits mTORC1 function (Cai et al., 2006; Inoki, L Zhu, Wu, & Guan, 2002). Similarly, 
phosphorylated PRAS40 breaks apart with the regulatory-associated protein of mTOR (Raptor) 
protein in mTORC1, enabling Raptor to recruit mTORC1's substrates: S6K1 and 4E-BP1 
(Oshiro et al., 2007; Vander Haar, Lee, Bandhakavi, Griffin, & Kim, 2007). 
        The PI3K/AKT pathway represses Pax5 expression through sequestering its activator Foxo1 
from the nucleus and supporting the expression of its inhibitor IRF4 (W. H. Lin et al., 2015). 
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AKT phosphorylates the transcription factor forkhead box O1 (FoxO1), leading Foxo1 to be 
bound by 14-3-3 protein (Biggs, Meisenhelder, Hunter, Cavenee, & Arden, 1999). The 14-3-3 
proteins are a family of proteins that prefer to bind to specific phosphorylated serine and 
threonine motifs (Obsil & Obsilova, 2011). One of the 14-3-3 interacting motifs in FoxO1 
overlaps with the C-terminal basic region of the DNA-binding domain. Because this region also 
includes the nuclear localization signal of FoxO1, the binding of 14-3-3 protein inactivates 
FoxO1’s DNA binding activity and promotes its shuttling from the nucleus to cytoplasm (X. 
Zhao et al., 2004).  
        In addition to hijacking the activator of Pax5, activation of the PI3K/AKT/ mTOR pathway 
also augments the expression of IRF4, which represses Pax5 expression at higher concentrations 
(Sciammas et al., 2006). An early study showed that overexpression of IRF4 in Oci-Ly7, a cell 
line derived from human germinal center B cells, repressed a group of genes highly expressed in 
germinal center B cells, including Pax5, Bcl6, and Aicda (Sciammas et al., 2006). Similarly, our 
group has used IRF4 knockout mice to demonstrate tht IRF4 is essential for the downregulation 
of Pax5. In LPS-stimulated mature B cell cultures, IRF4 knockout B cells retain their Pax5 high 
phenotype, even after they have undergone sufficient numbers of cell divisions that Pax5 
repression is observed in wild-type cells under the same conditions (W. H. Lin et al., 2015). In 
the same study, we also demonstrated that the chemial inhibitors PI3K, AKT, or mTOR could 
suppress the Pax5 downregulation and IRF4 up-regulation in wild-type B cell cultures. Taken 
together, PI3K signaling pathway-induced Pax5 suppression is partially mediated by 





1.3 T cell maturation and differentiation  
1.3.1 Early T cell development in the thymus 
Despite the progenitors of B cells and T cells sharing some key transcription factors, such 
as PU.1, Runx1/CBFβ, and Ikaros, their lineage commitment pathways differ significantly in 
several respects. First, the developmental events for B cells happen predominantly in the bone 
marrow, whereas those for T cells happen in the thymus. Therefore, bone marrow-derived 
progenitors need to exit the bone marrow, move within the bloodstream, and home to the thymus 
throughout the life span. However, studies about the identification of multi-potent progenitors 
that migrate through the blood stream to populate the thymus have remained controversial. 
Perhaps more than one progenitor population contributes to replenish the progenitors in thymus 
through distinct homing mechanisms (Zlotoff & Bhandoola, 2011). The most promising 
candidates are LMPP and CLP. 
      Second, the progenitors of T cells have relatively broad potential to further differentiate into 
other lineages. B cell commitment occurs after Pax5 upregulation in pro-B cells, whereas the T 
cell commitment is not complete until after sequential lineage exclusion steps block the potential 
to become macrophages, granulocytes, DCs, and NK cells (Cobaleda, Schebesta, Delogu, & 
Busslinger, 2007). The early thymic progenitors derived from LMPP and CLP are characterized 
by KithiLI-7Rlow. They differentiate into KithiLI-7Rlow double-negative (DN)2a cells. The T cell 
commitment happens during the transition from the DN2a to DN2b stage. In the DN2a stage, the 
expression of transcription factor Bcl11b is induced by the Notch pathway and multiple 
transcription factors, including CSL, Tcf-1, GATA3 and Runx1 (Kueh et al., 2016). The 
expression of Bcl11b restricts the potential of T cells to differentiate into NK cells, myeloid and 
dendritic cells (Li, Leid, & Rothenberg, 2010). Once they enter the DN2b stage, these pro-T cells 
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start to rearrange the TCRβ, TCRδ and TCRγ loci. 
     Third, Notch1 signaling is essential for T cell lineage commitment from bone marrow 
progenitors stages until they have passed the β-s lection checkpoint. By contrast, the function of 
Notch signaling during early B-cell development remains unclear, but Pax5-mediated repression 
of Notch1 is part of the mechanism of B cell lineag commitment and repression of T cell 
lineage commitment (Souabni, Cobaleda, Schebesta, & Busslinger, 2002). 
     Only after their transition from DN3a to DN3b stage can pro-T cells stop relying on Notch 
signaling. It is during this transition that the successfully rearranged TCRβ chain pairs with pre-T 
cell receptor alpha to form pre-TCR. The cells thatgenerate functional pre-TCR are stimulated 
by pre-TCR signals for survival and proliferation, whereas those cells that fail to produce 
functional pre-TCR are eliminated by apoptosis. Thus, this checkpoint of T cell development is 
called β selection. 
 
1.3.2 Effector and memory T cell-fate decisions 
Until now, the mechanism and time point for generation of memory T cell after infection 
has remained unclear. Indeed, how one defines a memory T cell lies at the heart of this dispute. 
One of the most widely used definitions is based on the time that the antigen specific cells persist. 
That is, antigen specific memory cells can be detect d months after infection or exposure to 
antigen. However, this definition cannot be applied to study the early development of effector 
and memory cells after infection. Therefore, some studies have defined memory cells by their 
functional characteristics, including their ability to undergo rapid proliferation in response to 
antigen and to undergo homeostatic proliferation when they are stimulated by cytokines (such as 
IL15 and IL-7) (Kaech, Hemby, Kersh, & Ahmed, 2002). Other studies have proposed that the 
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memory T cells can be subdivided into two groups with d fferent homing potentials and effector 
functions by measuring their surface expression of CCR7 and CD62L (Sallusto, Lenig, Forster, 
Lipp, & Lanzavecchia, 1999). The CD62L-/CCR7- effector memory T (TEM) cells are attracted to 
inflamed tissues and can perform immediate effector function, whereas the CD62L+/ CCR7+ 
central memory T (TCM) cells home to lymph nodes but lack immediate effector function. In 
addition, TCM can differentiate into CCR7
- effector cells when re-challenged by antigens. 
     As previously discussed in Section 1.1, one of the basic developmental questions about the 
generation of effector and memory cells is whether a single cell is sufficient to generate 
daughters with distinct function and longevity. The “one cell, one fate” hypothesis states that one 
activated T cell can only give rise to daughter cells with the same cell fate; thus, distinct fates 
should emerge only from different naïve T cells. By contrast, the “one cell, multiple fate” 
hypothesis states that a single T cell can generate p ogenies with diverse phenotypes and 
functions that one observes in a T cell response. This question is now partially resolved by 
single-cell adoptive transfer technology. Using an injection system monitored by microscopy, 
Stemberger and colleagues demonstrated that an adoptively transferred single naive OT-I T cell 
(a FACS-enriched CD45.1+ CD44low TCR-transgenic cell) expanded into diverse populations as 
characterized by surface expression levels of CD62L and CCR7 and by differential expression of 
cytokines, including IFN-γ, IL-2, and TNF-α, in response to Listeria infection (Stemberger et al., 
2007). The pattern of surface marker and cytokine production in a single cell-derived population 
is indistinguishable from that of endogenous epitope-reactive T cells, suggesting a single T cell 
can generate the full repertory of functional T cell families after infection; thus, this result is a 
strong support for the one cell, multiple fate hypothesis. 
    Although the single cell transfer assay is a useful tool for mapping the fate of the founding 
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ancestor at single-cell resolution, it can only capture a snapshot of the daughters at a specific 
time point. Thus, this technique cannot record the branching process of all daughters derived 
from a single T cell in vivo. Therefore, the next question is when and how fate determination 
happens during the immune response. Traditionally the development of memory T cells has been 
described by the linear differentiation model, which proposes that the branch point for 
differentiation into effector or memory T cells does not happen until the population enters the 
contraction phase (Ahmed & Gray, 1996; Wherry et al., 2003). This model proposed a linear 
differentiation pathway: naïve T cells become effector T cells, which give rise to TEM, and then 
TEM become TCM. However, several recent discoveries have challenged this model and alternate 
models have been proposed to explain the new observations. 
     The linear differentiation model is based on observations made in the settings of acute 
lymphocytic choriomeningitis virus (LCMV) and Listeria monocytogenes (LM) infections, 
which are characterized by clearance of pathogens and generation of CD8+ memory cells, which 
can perform recall proliferation and differentiation into effector cells after reencountering 
antigen. However, this model did not explain the mechanism for generating heterogeneous 
effector and memory T cells and failed to explain why CD8+ T cells become defective in chronic 
infections where antigen persists (D'Souza & Hedrick, 2006; Renno, Hahne, Tschopp, & 
MacDonald, 1996). 
       An alternative model is the decreasing potential model, which holds that activated CD8+ T 
cells progressively lose their ability to differentiate into memory cells and become more 
terminally differentiated during rounds of division (Ahmed & Gray, 1996). The number of 
divisions is positively correlated with the strength and duration of antigen stimulation. Therefore, 
only optimal stimulation strength leads to enough T cell expansion for the generation of 
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functional memory cells and effector cells (Sarkar et al., 2007). Weak stimulation leads to 
limited T-cell expansion and impaired memory development, whereas persistent stimulation 
leads to generation of exhausted effector T cells(Renno et al., 1996; Williams & Bevan, 2004). 
The generation of TCM and TEM is also associated with the duration of antigenic stimulation. The 
TCMs are generated by short antigenic stimulation, whereas TEMs and effector T cells are 
generated by prolonged antigenic stimulation (van Fassen et al., 2005). 
 
1.3.3 Transcription factors of memory or effector T lymphocyte differentiation  
      Despite the developmental pathway and mechanism for generating memory and effector T 
cells not being fully understood, many key transcription factors that participate in the early 
development of T cells in thymus have been found to play a role in maintaining memory cells or 
in differentiation into effector cells. Some factors are required for promoting memory cell 
development, survival, and self-renewal, whereas others support the effector function of T cells. 
The former includes TCF1 and FoxO1, and the latter includes Bcl11b, T-bet, and Blimp-1. 
      For example, the T cell lineage commitment is regulated by Tcf-1 and Bcl11b. TCF1 
knockout T cells fail to generate and maintain the memory T cells (Zhou et al., 2010), whereas 
the deletion of Bcl11b impairs the function of effector CD8+ T cells and affects the 
differentiation of CD4+ T cell subsets (Avram & Califano, 2014).  
      In addition, the protein level of Foxo1 in meory-precursor T cells is higher in comparison 
with that in effector T cells. Mice with conditionally-silenced Foxo1 in CD8+ T cells fail to elicit 
an efficient secondary immune response against Listeria monocytogenes (M. V. Kim, Ouyang, 
Liao, Zhang, & Li, 2013). Moreover, Foxo1 has been d monstrated to bind to the regulatory 
region of the Tcf-1 gene by chromatin immunoprecipitation sequencing assay (M. V. Kim et al., 
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2013). These data collectively suggest that Foxo1 is required for the differentiation and 




1.4.1 The connection between metabolism and the immune system 
An effective immune response requires different types of immune cells to reprogram their 
metabolic configurations, enabling them to adopt dis inct requirements of nutrient catabolism, 
anabolism, cell proliferation, and longevity. Immunometabolism is an area of study aimed to 
decipher the connection between metabolism and the immune system (Loftus & Finlay, 2016; 
O'Neill, Kishton, & Rathmell, 2016a). Understanding how distinct metabolic configurations in 
various cell types facilitate pathogen defense and support immune function holds tremendous 
hope for improving the efficiency of vaccination and immune therapy as well as the 
prevention and treatment of auto-immune disease. 
     Metabolic reprogramming is essential for fulfilling various cellular activities, including 
energy supply, anabolism, translation, transcription, posttranslational modifications, secretion, 
migration, proliferation, survival, redox balance. It is thus associated with several immune 
functions such as differentiation, the production and secretion of antibody and cytokine, 
maintenance of memory populations, and rapid proliferation after activation by antigens. For 
example, the metabolism of glucose is essential for supporting several immune functions of 
cytotoxic CD8+T cells. Glycolysis is one of the basic metabolic pathways for cells to generate 
ATP and to prepare materials for anabolism. Moreover, th  synthesis of cytokine interferon-γ 
(IFN-γ) relies on glucose availability, because glucose deprivation inhibits IFN-gamma 
transcription and de novo protein synthesis (Cham & Gajewski, 2005). The secretion of IFN-γ 
is also dependent on glycolysis (Cretenet et al., 2016).  
     The byproducts of metabolism are also involved in signaling pathways. Reactive oxygen 
species (ROS) are generated during cellular energy production, especially by aerobic 
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metabolism and mitochondrial respiration (Giorgio, Trinei, Migliaccio, & Pelicci, 2007).  ROS 
play crucial roles in several biology functions of T cells (Belikov, Schraven, & Simeoni, 2015). 
Activated phagocytes are the extrinsic ROS source for T cells. Activated T cells trigger 
respiratory burst in phagocytes, which produce H2O2 that penetrates into T cells or oxidizes 
proteins on the plasma membrane of T cells (Cemerski, Cantagrel, Van Meerwijk, & 
Romagnoli, 2002; Flescher et al., 1994). In addition, there are several sources producing ROS 
in T cells; H2O2 is produced by DUOX-1 and NOX-2, and superoxide anion (O2
•−) is 
generated by the electron transport chain of the mitochondria. Carefully controlled equilibrium 
between ROS and antioxidants is required for a normal i mune response. First, NOX-2-
derived ROS suppress the differentiation of Th17 but support the differentiation of Th2 T cells. 
In T cell-specific NOX-2 (p47 subunit) knockout mice, the expressions of T-bet, STAT-1, and 
STAT-4 are diminished, but expression of phosphorylated STAT-3 is enhanced, suggesting 
NOX-2 deficiency favors differentiation into Th17 but suppresses that of Th2 (Shatynski, 
Chen, Kwon, & Williams, 2012; Tse et al., 2010). Second, ROS generation by complex I after 
TCR signaling induces expression and secretion of cyt kines IL-2 and IL-4 and activation of 
transcription factors NF-κB and AP-1 (Kaminski et al., 2010). Third, ROS amplify the TCR 
signal in activation-induced cell death, which is an important mechanism to terminate the 
immune response after foreign antigens are cleared (B likov, Schraven, & Simeoni, 2014). 
 
1.4.2 Distinct metabolic programs in effector and memory lymphocytes 
The detailed molecular mechanism and developmental pa hway of effector and memory 
T cells has remained under debate. Several models have been proposed, each supported by 
different experiments. The three most commonly compared models are the dedifferentiation 
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model, the decreasing potential model, and the divergent lineage model (Joshi & Kaech, 
2008). 
     The rapid proliferation and enhanced extracellular acidification rates of activated T cells 
suggest these cells undergo dramatic remodeling of their metabolic and transcriptional 
programs to fulfill the demand for energy and macromolecular building blocks during the 
generation of effector cells. In the previous sections, we have discussed several key 
transcription factors that have been shown to be ess ntial for establishing lineage 
commitment and for maintaining the identity of effector and memory T cells. Here, we are 
focused on metabolic reprogramming and its link to the function and survival of effector and 
memory T cells.  
     Naïve T cells mainly rely on mitochondrial-dependent oxidative phosphorylation and fatty 
acid β oxidation to support their basal energy consumption. By contrast, activated, fast-
dividing T cells rely on elevated aerobic glycolysis and glutamine oxidation together with 
oxidative phosphorylation. Most of the effector T cells are dead at the end of immune 
response; however, some of them survive and become memory cells by adopting a metabolic 
program similar to that of naïve T cells, and return to a quiescent state like adult stem cells.  
      The impact of perturbation of the metabolic programs on the differentiation of effector 
and memory T cells has been studied with mTORC1 and AMPK. Blocking mTORC1 with 
rapamycin promotes the differentiation of the memory-liked T cell population in in vitro and 
in vivo studies (Araki et al., 2009). On the other and, stimulating AMPK, which is a 
negative regulator of mTORC1, with metformin also pr motes the formation of memory T 
cells, whereas deletion of AMPK blocks the transition to a memory T cell fate (E. L. Pearce 
et al., 2009). 
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     Directly targeting some rate-limiting enzymes al o results in dramatic changes in the 
development of memory T cells. The over-expression of carnitine palmitoyl-transferase 
(CPT1), a key enzyme of β oxidation, augments the fraction of memory T cells (van der 
Windt et al., 2012), whereas over-expression of the glycolytic enzyme PGAM1 limits the 
capacity of activated T cells to generate immune cells (Sukumar et al., 2013). 
      Unfortunately, the link between metabolic and transcriptional reprogramming remains 
unclear. There is evidence suggesting that the metabolic status is associated with intracellular 
AMP to ATP ratio, which can be sensed by AMPK. A high AMP condition activates AMPK, 
which suppresses and antagonizes the effect of mTOR, accelerating translation and 
proliferation (W. H. Lin et al., 2015). Also, previous reports and our data have both 
demonstrated that inhibition of glycolysis by 2-deoxyglucose (2-DG) during T cell activation 
prevents the expression of the effector-like transcriptional program and the production of 
antigen specific memory cells (Sukumar et al., 2013). 
 
1.4.3 The PI3K/AKT/mTOR pathway, AMPK and metabolism 
In the earlier sections, we have introduced AKT’s ability to activate mTOCR1 by multiple 
pathways. In this section we are going to focus on the different functions of mTPCR1 and 
mTORC2 and their agonist AMPK on fine-tuning the metabolic program. 
   Both mTOR, a serine-threonine kinase, and AMPK, a serine-threonine kinase protein 
complex, are evolutional conserved. mTORC1 and mTORC2 share three proteins: the 
catalytic subunit mTOR, the DEP domain-containing mTOR-interacting protein (Deptor), and 
mammalian lethal with SEC13 protein 8 (mLST8) (Peterson et al., 2009). However, mTORC1 
includes Raptor and proline-rich AKT substrate 40 kDa (PRAS40) (Hara et al., 2002; Sancak 
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et al., 2007). By contrast,  mTOCR2 encompasses rapamycin-insensitive companion of mTOR 
(Rictor), mammalian stress-activated protein kinase interacting protein (mSIN1), and the 
protein observed with Rictor-1 (Protor-1) (L. R. Pearce et al., 2007; Sarbassov et al., 2004; 
Yang, Inoki, Ikenoue, & Guan, 2006). 
An early study showed that rapamycin treatment alsoenhances memory T-cell responses, 
suggesting that memory T-cell differentiation is regulated by mTOCR1 
(Araki et al., 2009). Indeed, later studies have demonstrated that mTORC1 influences CD8+ T 
cell effector responses, whereas mTORC2 activity regulates CD8+ T cell memory. Deletion of 
TSC2, a repressor of mTORC1, prevents CD8+ T cells from differentiating into memory cells 
and helps them retain effector characteristics. In co trast, mTORC2 inhibition helps to 
increase the number of CD8+ memory cells (Pollizzi et al., 2015). 
     Moreover, when memory CD8+ T cells are activated by antigens, a rapid reprogramming of 
their glycolytic activity occurs, providing a subsequent ability to re-acquire effector functions. 
Such immediate early glycolysis in memory CD8+ T cells is inhibited by OSI-027, an 
mTORC1-mTORC2 inhibitor, but not by rapamycin, suggesting that mTORC2, rather than 
mTOCR1, is associated with the glycolytic switch (Gubser et al., 2013).  
 
1.4.4 AMPK and metabolism 
AMPK is an important sensor and regulator of cellular energy production and response to 
various stress conditions, including a low level of ATP, high amounts of reactive oxygen or 
nitrogen species, and a high calcium concentration (Cardaci, Filomeni, & Ciriolo, 2012). AMPK 
is the major regulator of transcription factor PGC1-alpha, which is the key regulator that controls 
the production of genes related to mitochondria renewal (Canto & Auwerx, 2009).  AMPK also 
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antagonizes the activation effect of AKT on Foxo1 and mTOR by activating the TSC1/TSC2 




1.5 Mitochondria and immunity 
1.5.1 The regulators of mitochondrial motion, fusion, and fission  
   Mitochondria not only play a role in energy production but also in diverse cellular activities, 
including anabolism, calcium and iron homeostasis, ROS production, apoptosis, and the immune 
response. To date, our knowledge about regulatory proteins involved in mitochondrial shaping, 
motion, and morphology is largely from studies of Saccharomyces cerevisiae (Altmann & 
Westermann, 2005; Dimmer et al., 2002). Although several homologous genes have been found 
in higher eukaryotes, their functions do not exactly recapitulate their homologs in yeast. For 
example, mitochondrial transportation in mammalian cells relies mainly on microtubules, 
whereas in yeast, mitochondrial transportation is more dependent on the actin cytoskeleton 
(Boldogh, Fehrenbacher, Yang, & Pon, 2005; Chada & Hollenbeck, 2004). Detailed mechanisms 
for how mitochondria segregate into daughter cells r main largely unclear in mammalian cells. 
In this introduction section, I mainly focused on ma malian systems. 
    Mitochondrial transportation and quality control are regulated by three activities: 
mitochondrial movement, fission, and fusion. The transportation of mitochondria along 
microtubule networks relies on two families of motor proteins: the kinesins and dyneins (Tanaka 
et al., 1998; Varadi et al., 2004). In addition, Milton and Miro (RhoT1/2) are two important 
adaptor proteins that form the mitochondrial motor/adaptor complex, which links the motor 
proteins to the mitochondria. Milton is the adaptor protein that connects Miro to the motor 
proteins, whereas the Miro is a transmembrane protein that anchors to the mitochondrial outer 
membrane through its C-terminal transmembrane domain (Fransson, Ruusala, & Aspenstrom, 
2006; Glater, Megeath, Stowers, & Schwarz, 2006). Miro has two GTPase domains, which are 
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distantly related to the Ras superfamily of small guanosine triphosphatases (GTPases), separated 
by a pair of EF hand domains, which indicates that e activity of Miro can be regulated by the 
level of Ca2+ (Fransson et al., 2006). One of the ways to regulate the motion of mitochondria is 
that when Ca2+ binds to these EF hands domains in Miro protein, Miro reversibly disengages 
from microtubules. Using cultured embryonic hippocamp l neurons derived from mice and rats, 
PINK1 and Parkin have been reported to induce proteasomal degradation of Miro by 
phosphorylated Miro and by ubiquitinylate Miro, resp ctively (X. Wang et al., 2011).  
       Mitochondrial morphology, fusion, and fission are regulated by Dynamin-related large 
GTPases: dynamin-related protein 1 (Drp-1), the mitofusins (Mfn1 and Mfn2), and Opa1 
(Olichon et al., 2002; Santel et al., 2003; Smirnova, Griparic, Shurland, & van der Bliek, 2001). 
Drp-1 proteins are in the cytosol and are recruited to mitochondria by mitochondrial outer 
membrane proteins, such as mitochondrial fission 1 (Fsi1), mitochondrial fission factor (MFF), 
Mitochondrial dynamics protein of 49 kDa (MID49), and 51 kDa (MID51) (Loson, Song, Chen, 
& Chan, 2013). When assembling on and wrapping around the mitochondrial outer membrane, 
oligomeric Drp-1 proteins cause the constriction of mitochondria and thus facilitate 
mitochondrial fission (Yu, Fox, Burwell, & Yoon, 2005). By contrast, mitochondrial fusion is 
regulated by mitochondrial outer membrane proteins Mfn1 and Mfn2 and by mitochondrial inner 
membrane protein Opa1, which mediate the effusion of mitochondrial inner membrane (Olichon 
et al., 2002; Santel et al., 2003). 
      Mitochondrial morphology is coordinated with the cell cycle. In G1 phase, mitochondria 
form an interconnected network, which is fragmented when cells enter mitosis (Taguchi, Ishihara, 
Jofuku, Oka, & Mihara, 2007). This transition occurs because cyclin–CDK activity not only 
drives cell cycle progression but also regulates th transcription, stability, and activity of 
24 
 
mitochondrial fission proteins. On the transcriptional level, when CDK activates the transition 
from G1 to S phase, pRb is phosphorylated by CDKs. Phosphorylated pRB breaks apart from 
the pRB/E2F complexes, which enables E2F to activate the transcription of several 
mitochondrial function genes (Ambrus et al., 2013; Blanchet et al., 2011; Sankaran, Orkin, & 
Walkley, 2008). Moreover, when the cyclin-B-CDK complex is activated as a cell enters 
metaphase, it activates Drp-1 through phosphorylation (Taguchi et al., 2007). Also, during 
metaphase, mitotic kinase Aurora A phosphorylates RALA, which forms a complex with 
RALBP1 and cyclin B–CDK1 on mitochondria that mediates the phosphorylation of Drp-1 
(Kashatus et al., 2011). The fission activity is inactivated at the end of telophase, when the 






Figure 1.1 The regulators of mitochondrial motion, fusion and fission  
     The mitochondrial life cycle involves biogenesis, fsion, turnover, and fusion. The fission 
and fusion of mitochondria is regulated by Cyclin-dependent kinases (CDKs) and anaphase-
promoting complex (APC). In S phase, CDK1-cyclinB complex phosphorylates Drp-1 and 
triggers mitochondrial fission. Therefore, the mitoch ndrial network is fragmented at the G2 and 
M phase. When APC triggers the completion of metaphase, APC targets Drp-1 for degradation. 




1.5.2 The linkage between mitochondrial function and the immune system 
Mitochondria are multifunctional organelles. They srve not only as energy factories and 
biosynthetic factories but also as the major mediators of apoptosis and a hub in the innate 
immune system (Ernster & Schatz, 1981; X. Wang, 2001; West, Shadel, & Ghosh, 2011). Recent 
studies, however, have also implicated that mitochondria are signaling organelles influencing 
differentiation, proliferation, and aging. In both innate and adaptive immune cells, mitochondria 
are necessary for guiding lymphocyte differentiation and for fulfilling cell-type specific 
metabolic demands of different immune cells. Indeed, the development and differentiation of NK 
cells, T cells, and B cells are all reportedly linked with mitochondrial functions (Jang et al., 2015; 
van der Windt et al., 2012; S. Wang et al., 2016).  
    It has been demonstrated that memory T cell and memory NK cell formation can be enhanced 
by treating an immunized animal with rapamycin, which is a pharmacologic molecule that 
induces autophagy by inhibition of mTOR (Araki et al., 2009; T. E. O'Sullivan, Johnson, Kang, 
& Sun, 2015). Moreover, an early study on immune response to S. aureus infection found that 
rapamycin treatment blocked the differentiation of human B lymphocytes into antibody-secreting 
cells (Aagaard-Tillery & Jelinek, 1994). 
 
1.5.3 The mitochondrial quality control system 
    Despite mitochondria playing an important role in providing energy and nutrient homeostasis, 
as well as in signaling pathways, accumulation of damaged mitochondria causes cell death and 
tissue dysfunction and increases oxidative stress by producing excessive reactive oxygen species 
(ROS) (Cleeter, Cooper, Darley-Usmar, Moncada, & Schapira, 1994). Therefore, a sophisticated 
quality control mechanism has been evolved to repai and to replace damaged mitochondria 
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(Ashrafi & Schwarz, 2013).  
    Because mitochondrial DNA only encodes less than 40 genes, the majority of the 
mitochondrial proteins are encoded in the nucleus (Taanman, 1999). These proteins are 
translated in the cytosol and are transported through mitochondrial membranes to their 
destination: to integrate into the outer/inner membranes, the intermembrane space, or the matrix. 
The first line of defense to prevent the accumulation of misfolded or damaged protein in 
mitochondria is through the mitochondrial unfolded protein response. In the matrix, damaged or 
misfiled proteins are degraded by soluble protease complexes (Lon and Clp family proteases) (de 
Sagarra et al., 1999; Q. Zhao et al., 2002), metallopeptidase Oma1 (Kaser, Kambacheld, Kisters-
Woike, & Langer, 2003), and m-AAA proteases (Arlt, Tauer, Feldmann, Neupert, & Langer, 
1996).  In the inter-membrane space, undesired proteins are removed by the i-AAA protease, 
which is also a member of the AAA proteases. These proteases degrade their substrates to 
oligopeptides, which are further degraded to amino acids by mitochondrial oligopeptidases 
(Kambacheld, Augustin, Tatsuta, Muller, & Langer, 2005) or expelled from mitochondria 
(Augustin et al., 2005). 
    Damaged mitochondrial proteins can also be removed by a mitochondria–lysosome transport 
pathway. Vesicles budding from the mitochondria have been found to carry selected proteins to 
target the peroxisomes or lysosomes (Neuspiel et al., 2008; Soubannier et al., 2012). These 
mitochondria-derived vesicles (MDVs) are coated with mitochondrial outer membrane protein 
Tom20, rather than autophagosome marker LC3, suggestin  that they are not generated from an 
autophagy or mitophagy pathway. This pathway remains unaffected by silencing the 
mitochondrial fission Drp-1 or deleting the autophagy protein ATG5. Therefore, the mechanism 
functions independently of the quality control of the mitochondrial fission. 
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     As mentioned above, one of the ways to repair a damaged mitochondrion is through fusion 
with a healthy mitochondrion, whereby mixing components from the two mitochondria 
replenishes the damaged part of the malfunctioning mitochondria. However, for those instances 
where the damaged part cannot be fixed by fusion, or for mitochondria that lose their ability to 
undergo fusion, the fission mechanism enables the chopping away of the dysfunctional part for 
lysosome-mediated degradation: autophagy. Mitochondrial fusion and fission rates determine the 
lengths of mitochondria. Both fusion and fission involve members of the Dynamin GTPase 
family.  In mammals, Mitofusin-1 and Mitofusin-2 redundantly support the fusion of 
mitochondrial outer membranes (H. Chen et al., 2003), whereas Opa1 governs the fusion of 
mitochondrial inner membranes (Delettre et al., 2000). By contrast, mitochondrial fission in 
mammalian cells is mediated by a single Dynamin family protein−Drp-1 (Smirnova et al., 2001). 
In response to various types of stimulation, Drp-1 roteins are recruited to the mitochondrial 
outer membrane by interacting with its mitochondrial adaptors (such as Fis1, Mff and MIEF1) 
(Hoppins, Lackner, & Nunnari, 2007).  During fission, these Drp-1 proteins are then self-
assembled into spirals encircling the mitochondria (Smirnova et al., 2001). Recent live cell 
imaging studies have proposed that the Drp-1 ring dvides the mitochondria by a twisting 
mechanism rather than by constriction (Rosenbloom et al., 2014). 
     The entire mitochondria can be removed by macro- utophagy and mitophagy. Macro-
autophagy (generally referred to as autophagy) is a multi-step catabolic process in which 
cytoplasmic components and organelles are encapsulated by double-membrane vesicles called 
autophagosomes. Mature autophagosomes ultimately fuse with lysosomes for degradation of 
their contents by acidic hydrolases. Macro-autophagy non-selectively degrades mitochondria 
together with other cellular components. By contrast, damaged mitochondria can also be 
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removed by a more selective turnover mechanism called mitophagy. Mitophagy is triggered by 
signals from damaged mitochondria through Parkin-dependent or Parkin-independent pathways. 
In the Parkin-dependent pathway, the E3-ubiquitin ligase Parkin and mitochondrial 
serine/threonine-protein kinase Pink1 cooperatively work in a feed-forward amplification loop to 
regulate mitophagy (D. Narendra, Tanaka, Suen, & Youle, 2008; D. P. Narendra et al., 2010). In 
coupled mitochondria, PINK1 is constitutively imported into the inner mitochondrial membrane 
and degraded by Rhomboid protease PARL (Jin et al., 2010). In depolarized mitochondria, 
PTEN-induced putative kinase 1 (PINK1) accumulate on the outer mitochondrial membrane 
and activate Parkin, an E3-ubiquitin-protein ligase, by phosphorylating Parkin and ubiquitin 
(Kazlauskaite et al., 2014; Kondapalli et al., 2012). Phosphorylated Parkin ubiquitinates itself 
and other substrates of PINK1 (Shimura et al., 2000), leading to the amplification of signals for 
mitophagy (D. Narendra et al., 2008). 
    Although mitophagy has been shown to remove mitochondria that have lost membrane 
potential when Parkin is overexpressed in HeLa cells, in mice, deletion of PARK2, which 
encodes Parkin protein, did not alter mitochondrial membrane potential, evoke significant 
neurological dysfunction or result in a prominent cardiac phenotype (Damiano et al., 2014; D. 
Narendra et al., 2008; Perez & Palmiter, 2005). These data suggest the presence of Parkin-
independent mitophagy pathways. In Parkin-independent mitophagy, damaged mitochondria 
recruit autophagy receptor proteins (such as NIX, BNIP3, FUNDC1, and Cardiolipin) to re-
localize to the outer membrane, and then these receptors interact with LC3 and summon 
autophagosomes to remove the mitochondria (Bellot et al., 2009; Chu et al., 2013; Liu et al., 
2012; Schweers et al., 2007; Zhang et al., 2008). 
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1.5.4 The regulation of mitochondrial homeostasis by AMPK and mTORC1  
    In meeting shifting energy needs, mitochondrial b ogenesis and clearance are regulated by two 
protein complexes—5' AMP-activated protein kinase (AMPK) and mammalian target of 
rapamycin complex 1 (mTORC1)—which sense and integrat  different stress signals to regulate 
mitochondria activity. Although both protein complexes have a role in stimulating mitochondrial 
biogenesis, they work under distinct cellular conditions. AMPK is activated under a variety of 
stress conditions, including nutrient-poor conditions, whereas mTORC1 is activated in the 
presence of growth factors and abundant nutrients (Shaw, 2009).  
     mTORC1 regulates mitochondrial biogenesis at both the transcriptional and translational 
levels. One the one hand, mTORC1 controls mitochondrial biogenesis through facilitating the 
formation of the transcriptional complex of yin-yang 1 (YY1) and peroxisome-proliferator-
activated receptor coactivator-1α (PGC-1α) (Cunningham et al., 2007). The Raptor in mTORC1 
serves as a docking site for YY1 (Cunningham et al., 2007). mTORC1 phosphorylates YY1 at 
T30 and S365, which enhances the interaction between YY1 and PGC-1α (Blattler, Cunningham, 
et al., 2012; Blattler, Verdeguer, et al., 2012) and thus stimulates the expression of their targeted 
mitochondrial genes. 
One the other hand, mTORC1 mediates mitochondrial biogenesis through phosphorylating 
the eukaryotic translation initiation factor 4E (eIF4E)-binding proteins (4E-BPs) and ribosomal 
protein S6 kinases (S6Ks). Phosphorylated 4E-BPs releas  eIF4E (Morita et al., 2013), enabling 
the assembling of eIF4F complex, which is composed of eIF4E, eIF4A, and eIF4G, at the 5’ cap 
of mRNAs (Sonenberg, Rupprecht, Hecht, & Shatkin, 1979; Tahara, Morgan, & Shatkin, 1981). 
Phosphorylated S6Ks then phosphorylate S6, eIF4B, and PDCD4 (Dorrello et al., 2006; Fenton 
& Gout, 2011; Shahbazian et al., 2006). The phosphorylated PDCD4s are marked for 
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degradation (Dorrello et al., 2006), releasing eIF4A for translation initiation (Suzuki et al., 2008). 
Taken together, mTORC1 facilitates the assembly of the translation initiation complex and 
several essential genes required for cell growth, cell proliferation and anabolic processes 
(Laplante & Sabatini, 2012). 
     At the first glimpse, AMPK and mTORC1 share some similar functions, as they both 
promote glucose uptake and mitochondrial biogenesis (through phosphorylating PGC-1α). 
However, AMPK is activated by hypoxia, oxidative stre s, and nutrient starvation, which is the 
inverse pattern of mTORC1 (Cardaci et al., 2012). Therefore, unlike mTORC1, AMPK 
suppresses protein synthesis and stimulates autophagy to overcome the energy crisis. Indeed, 
AMPK can repress mTORC1 activity by directly phosphorylating regulatory-associated protein 
of mTOR (Raptor) and Tuberous Sclerosis Complex 2 (TSC2), an upstream inhibitor of the 
mTORC1 complex (Gwinn et al., 2008; Inoki et al., 2006). 
     AMPK activation favors autophagosome formation in multiple ways. First, AMPK represses 
mTORC1 directly by inhibiting Ratptor and indirectly by activating TSC2. Second, mTORC1 
inhibits Unc-51-like-kinase1 (ULK1) (Hosokawa et al., 2009), which is an initiating kinase of 
autophagosomes, whereas AMPK activates ULK1 by phosphorylating its Ser317 and Ser777 (J. 
Kim, Kundu, Viollet, & Guan, 2011). Third, AMPK induces mitochondrial fission by 
phosphorylating the Drp-1 receptor MFF on Ser155 and Ser172. These phosphorylations are 
required for MFF to recruit Drp-1 to the mitochondrial outer membrane and mediate 
mitochondrial fission (Toyama et al., 2016). Four, AMPK activates forkhead-box transcription 
factors, especially Foxo1 and Foxo3, by phosphorylation (Greer et al., 2007; Yun et al., 2014). 
Whereas AKT-mediated phosphorylation of the forkhead-box family of transcription factors 
prevents them from entering the nucleus (Brunet et al., 1999), AMPK-mediated phosphorylation 
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enhances the transcriptional activity of Foxo1 and Foxo3, which regulate numerous genes 
associated with autophagy and mitophagy. These genes include LC3b, Ulk2, BINP3, BINP3L, 
Atg5, Atg12, and Atg14 (Webb & Brunet, 2014). In sum, AMPK induces mitochondrial 
biogenesis and autophagy, and links mitochondrial fission with mitophagy to maintain cellular 
energy homeostasis and mitochondrial homeostasis. 
1.5.5 Mitochondrial dynamics in memory and effector cells 
In recent years, accumulating studies have pointed out that the remodeling of 
mitochondrial morphology and function is responsible for guiding lymphocytes to differentiate 
into effector cells or memory cells. For CD8+ T cells, effector T cells (CD44hi, CD62Llow) have 
punctate mitochondria, whereas memory T cells (CD44hi, CD62Lhi) have a network of long and 
fused mitochondria. Optic atrophy 1 (Opa1) is a protein required for fusion of the mitochondrial 
inner membrane (Olichon et al., 2002). Opa1 knockout T cells have a survival defect and cannot 
form memory T cells after adoptive transfer into recipient animals (Buck et al., 2016). Moreover, 
activated T cells have elevated mitochondria ROS production, which is a message to activate 
nuclear factor of activated T cells (NFAT)-mediated IL-2 production (Sena et al., 2013). 
        For B cells, activated B cells increase mitochondrial mass and membrane potential, but 
when they gradually differentiate toward plasma cells, mitochondrial mass and membrane 
potential decrease. Moreover, activated B cells with h gher ROS (staining by CM-H2DCFDA) 
tend to undergo class-switch recombination, whereas those that have lower ROS tend to 
differentiate into plasma cells (Jang et al., 2015).  
        Finally, the persistence of long-lived natur l killer cells requires BNIP3- and BNIP3L-
mediated mitophagy. The number and frequency of long- ived natural killer cells can be 
increased by treating them with rapamycin to inhibit mTOR, or by treating them with metformin 
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to activate AMPK (T. E. O'Sullivan et al., 2015). Taken together, in lymphocytes, including B 
cells, T cells, and NK cells, activation and effector function are associated with increased 
mitochondrial mass, membrane potential, and ROS production, whereas memory function is 
associated with reduced mitochondrial mass, membrane potential, and ROS production. 
      In this study, I uncover a more detailed molecular mechanism linking mitochondrial status to 
the transcriptional program in both B cells and T cells. I demonstrate that the mitochondrial 
status is sensed by AMPK and signaled through mitochondrial-derived ROS to alter the 
expression of Pax5 and Tcf7 in B cells and T cells, re pectively. 
 
1.5.6 Mitochondrial stasis is associated with stem cell identity, self-renewal, and fate 
decisions   
Similar to the observations made in memory and effector lymphocytes, stem cells and 
committed progenitors have been found to display different mitochondrial morphology. During 
neurogenesis in embryos, neural stem cells with self-renewal ability exhibit relatively elongated 
mitochondrial networks, whereas differentiated neural p ogenitor cells have relatively 
fragmented mitochondrial networks. Silencing mitochndrial inner membrane fusion protein 
OPA1 in Sox2+ uncommitted neural stem cells reduced the ability to form neurospheres in vitro 
and increased the frequency of commitment to nerve cells. Knockdown of mitochondrial outer 
membrane fusion proteins Mfn1 and Mfn2 in uncommitted cells results in similar defects in 
neurosphere formation. Knockdown of these mitochondrial genes results in increased 
mitochondrial ROS and cytoplasmic ROS as measured by MitoSox and dihydroethidium 
fluorescence, respectively (Khacho et al., 2016). 
     Mitochondrial stasis not only plays a role in guiding the differentiation of neural stem cells 
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during embryonic development but is also required for preventing senescence of the adult 
quiescent stem cells. In muscle tissues, defective autophagy causes stem cell senescence through 
the ROS-induced p16INK4a axis, and thus declined autophagy function has been linked to the 
impaired muscle stem cells’ (satellite cells’) regenerative capacity in aged mice and humans 
(Garcia-Prat et al., 2016). Inhibiting autophagy in oung cells by bafilomycin leads to 
mitochondrial accumulation and an increase in ROS. By contrast, inhibiting ROS with Trolox or 
stimulating autophagy with rapamycin prevents the sene cence phenotype and rescues the 
proliferative and regenerative abilities of geriatric satellite cells. 
      In addition to maintain the normal stem cell populations, mitochondrial renewal is associated 
with the stem-like cells in breast cancer. Using Snap-tag chemistry or photoactivatable green 
fluorescent protein to monitor the dynamics of mitoch ndrial apportioning in dividing stem-like 
cells showed that one of the daughter cells received more old mitochondria than the other. The 
daughter cells receiving less old mitochondria exhibit superior mammosphere-forming capacity 
compared with those cells accumulating more old mitochondria (Katajisto et al., 2015).  
       Collectively, these experiments point out the importance of maintaining mitochondrial 
quality and dynamics in preserving the self-renewal ability and potential to differentiate in stem 
cells and stem-like cells. Memory lymphocytes with self-renewal capacity are thought to be the 
fundamental population to establish long-term immunological memory. They remain quiescent 
until being re-challenged by antigen and differentiating into effector cells.  In this study, I 
identify that lymphocytes may apply mitochondrial quality control mechanisms to ensure that a 
limited number of activated lymphocytes can continue expansion and differentiation, after 




1.6 Glycolysis regulates lymphocyte functions 
1.6.1 Metabolism and lymphocyte functions 
    How does the reprogramming of metabolic pathways in diverse immune cell types shape 
the immune response? Different metabolic pathways are required to provide energy for growth, 
proliferation, survival, and executing immune functions. For example, inflammatory and rapidly 
proliferating immune cells are often dependant on aerobic glycolysis, whereas regulatory T cells, 
memory T cells, and many immune cells that exhibit longer lifespans tend to rely on fatty acid 
oxidation. Indeed, after activation, enhanced glycolysis can be observed in both adaptive and 
innate immune cells, including B cells, effector T cells, natural killer cells, macrophages and 
dendritic cells (O'Neill, Kishton, & Rathmell, 2016b). 
Although aerobic glycolysis is not the most efficient way to generate ATP, it can produce 
NADH, which can serve as a cofactor for many enzymes. The biosynthetic intermediates in 
glycolysis also supply materials to support rapid cell growth. Similarly, the intermediates of the 
TCA cycle can provide UDP-GlcNAc for the glycosylation of cell surface receptors and 
secretory proteins. Moreover, many metabolic enzymes play a second role in addition to 
metabolism to regulate cellular functions, thus linking metabolism with immune function. For 
example, GAPDH suppresses the translation of IFN-gamm  mRNA when it is not involved in 
glycolysis (C. H. Chang et al., 2013). Also, HK1 binds to mitochondrial VDAC1, which is 
required for activation of NLRP3 inflammasome in macrophages (J. S. Moon et al., 2015). 
In addition, several critical transcription factors involved in immune function also regulate a 
variety of metabolic pathways, such as Foxo1 and HIF-1 alpha (Tannahill et al., 2013). Taken 
together, the metabolic program is not just downstream to the transcriptional networks. 
Metabolic program can feedback to reprogram the transcriptional networks in different immune 
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cell types and in response to different stimuli. 
 
1.6.2 Autophagy, mTOR pathway, and memory cells 
      In 2009, Koichi Araki et. al. demonstrated that in mice infected with acute lymphocytic 
choriomeningitis virus, the number of virus-specific CD8+ T cells could be enhanced by 
treatment with rapamycin, which is an immune suppressive drug that inhibits T cell activation 
and proliferation. Using retrovirus based RNA interference (RNAi), the authors found that 
knockdown of Raptor, which is part of the mTORC1 complex, also enhanced memory T cell 
formation, suggesting rapamycin regulates memory cell differentiation through inhibiting the 
function of the mTOCR1 complex (Araki et al., 2009). 
       How is mTORC1 function linked to maintaining the number of memory cells? mTOR has 
been found to negatively regulate autophagy, which is an adaptive mechanism for recycling  
cellular components to provide amino acids during nutrient depletion and starvation. mTOR 
phosphorylates ULK1 and Atg13, an essential protein for autophagosome formation, under 
nutrient-enriched conditions (Hosokawa et al., 2009). Starvation and rapamycin treatments lead 
to dephosphorylation of ULK1, and thus the kinase activity of ULK1 is activated. Activated 
ULK1 initiates autophagosome formation by phosphorylating Atg13 and FIP200 (Ganley et al., 
2009; Jung et al., 2009). Conditionally knocking out either of the autophagy-related molecules 
Atg5 or Atg7 by Gzmb-Cre impairs the survival of virus-specific T cells during the contraction 
phase after LCMV Armstrong strain infection and prevents the formation of long-lived memory 
T cells (X. Xu et al., 2014). Metabolite analysis reveals that lipid and glycan-biosynthesis 
pathways ae altered in the Atg7 knockout T cells (X. Xu et al., 2014). A similar phenotype had 
been reported in transgenic mice in which tumour nec osis factor (TNF) receptor-associated 
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factor 6 (TRAF6) is conditionally knocked out in T cells. In these animals, effector T cell 
function remains intact, but the formation of memory T cells is abrogated. TRAF6-deficient 
CD8+ T cells are found to have defective fatty acid metabolism (E. L. Pearce et al., 2009). 
      A later study found that memory T cells do not directly import long chain fatty acids, but up-
take glucose to support de novo synthesis of fatty acids and use lysosomal acid lipase to provide 
substrates for fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS).  
Collectively, these experiments suggest that autophagy may be required for fueling 
mitochondrial FAO in memory T cells to supply the energy required for survival (D. O'Sullivan 
et al., 2014). 
 
1.6.3 Glycolysis and effector function of T cells 
The requirement of glycolysis to switch and to modulate the expression of glucose 
transporter has been reported in several studies. The mRNA of glucose transporter 1, 3, 6, and 8 
are detectable in Th1, Th2, Th17, and Treg populations (Macintyre et al., 2014). In all of the cell 
types, Glut1 is the predominant glucose transporter. In naïve T cells, Glut1 and Glut3 are highly 
expressed. In T cells stimulated by anti-CD3 and anti-CD28 in vitro, the expression of Glut1 
increases as stimulation time is prolonged, whereas the expression of Glut3 gradually decreases. 
The effects of conditionally knocking out Glut1 in CD4+ and CD8+ T cells have also been 
reported (Macintyre et al., 2014). Deletion of the loxP-flanked Glut1 alleles in early double-
negative (DN) thymocytes by Lck-Cre results in a drmatic reduction of the total number of 
thymocytes to only 30% of that in a wild-type animal. This is because of the reduction of CD4 
CD8 double-positive and CD4 single-positive cells, but not double negative cells. By contrast, 
deletion of the loxP-flanked Glut1 alleles in the DP-to-SP transition by CD4-Cre did not 
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significantly alter the number of thymocytes, suggesting that Glut1 is dispensable for the survival 
of the single positive thymocytes. Although the number of CD4+ and CD8+ T cells in the spleen 
and inguinal lymph nodes in CD4-Cre Glut1fl/fl  mice remains similar to that of wild-type mice, 
the ability of Glut1-knockout CD8+ and CD4+ T cells to homeostaticly proliferate is reduced in 
in irradiated and lymphopenic recipients. For CD8+ T cells, the effect of Glut1 deletion is less 
obvious. Although in vitro stimulated CD4 Cre-Glut1fl/fl  CD8+ T cells divide more slowly than 
wild-type CD8+ T cells, the effector function of CD8+ T cells to express and release granzyme B, 
IL-2, tumor necrosis factor alpha, and interferon gamma (IFNγ) remains unaffected by Glut1 
deletion, implying that the function of Glut1 can be compensated by over-expression of other 
glucose transporters. Indeed, western blot and proteomic data reveal that Glut1 knockout CD8+ T 
cells may up-regulate Glut3 and Glut6 expression (Hukelmann et al., 2016; Macintyre et al., 
2014). For CD4+ T cells, knocking out Glut1 not only affects the differentiation into Th1 and 
Th17 subsets but also impairs the proliferation of effector CD4+ T cells in vitro and in vivo. 
Interestingly, the differentiation and in vivo functions of Tregs are less affected by Glut1 
deletion, suggesting they may adopt alternative metabolic pathways (Macintyre et al., 2014). 
 
1.6.4 The role of glycolysis in B cells and plasma cells 
The phenotype of lost Glut1 in B cells is similar to that of T cells. The number of peripheral B 
cells is reduced in CD19-Cre Glut1fl/fl  mice because of the reduction of mature B cells 
(IgMhiB220+). However, the frequency of immature B cells (IgMlowB220+) in CD19-Cre Glut1fl/fl  
mice is increased, suggesting the presence of a developmental problem. The effector function of 
B cells is also affected by Glut1 deletion. The steady state serum IgM levels as well as the levels 
of serum IgM and IgG induced by immunization with NP-ovalbumin are dramatically reduced in 
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CD19-Cre Glut1fl/fl  mice (Caro-Maldonado et al., 2014). 
    Another study focused on long-lived plasma cells (LLPCs) demonstrated an additional layer 
function of glucose metabolism for maintenance of the memory and function of antibody secretin 
plasma cells. The data showed that LLPCs constitutively import Glucose to generate pyruvate for 
mitochondrial energy production and to glycosylate ntibodies (Lam et al., 2016). 
 
1.6.5 HK2, AKT, and mTORC1 
       Hexokinase catalyzes the first reaction in glycolysis. It phosphorylates glucose and produces 
glucose-6-phosphate (G6P), which is the rate-limiting step in glycolysis. There are 4 hexokinase 
isozymes (hexokinase I to IV) encoded by the mammalian genome (Roberts & Miyamoto, 2015). 
The expressions of these isozymes are tissue specific. Among them, hexokinase II (HK2) is the 
dominate isozyme expressed in insulin-sensitive tissue  and proliferating cancer cells (J. Chen, 
Zhang, Li, Tang, & Kong, 2014; Heikkinen et al., 2000).  
     In most cell types, such as in skeletal and car iac muscle cells, the activity of HK2 is 
regulated by the PI3K/AKT/mTORC1 pathway from multiple ways. First, AKT and mTORC1 
are positive transcriptional regulators of HK2 (Osawa, Sutherland, Robey, Printz, & Granner, 
1996; Printz et al., 1993). Because HK2 is a constitutively activated enzyme, the expression level 
of HK2 determines its cellular activity. Second, AKT directly phosphorylates HK2 and targets 
HK2 to the voltage-dependent anion channels on the mitochondrial outer membrane (Nakashima, 
Mangan, Colombini, & Pedersen, 1986; Roberts, Tan-Sh, mith, & Miyamoto, 2013). 
Therefore, HK2 can use the ATP produced by mitochondria for powering the energy donation 
steps in glycolysis (Arora & Pedersen, 1988). Third, AKT-mediated phosphorylation also lowers 
the sensitivity of HK2 to the feedback inhibition of its product G6P (Ardehali et al., 1996; 
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Roberts et al., 2013). G6P not only negatively regulates the activity of HK2 but also dissociates 
HK-II from mitochondria (Roberts et al., 2013; Rose & Warms, 1967). Finally, inhibition of 
mTORC1 activity with rapamycin has been shown to enhance the expression of micro-RNA 143, 
suggesting mTORC1 stabilizes HK2 mRNA by suppressing the micro-RNA that targets the HK2 
mRNA for degradation (Fang et al., 2012).  
    On the other hand, HK2 also regulates mTORC1 activity through protein-protein interaction. 
In addition to its enzyme activity, HK2 has been shown to stimulate autophagy in a glucose-
limited environment (Figure 1.2). Under glucose deprivation conditions, HK2 uses its TOS motif 
(TOR signaling motif) to directly bind to Raptor in mTORC1 and thus inhibits mTORC1-
mediated repression of autophagy (Roberts, Tan-Sah, Ding  Smith, & Miyamoto, 2014; Schalm 
& Blenis, 2002). 
 
1.6.6 The regulation of PI3K on glucose transporter Glut1 
During the development, differentiation, and activation of lymphocytes, PI3K integrates 
activation signals from a wide range of receptors, such as BCR and CD19 on B cells, TCR and 
C28 on T cells, and different cytokine receptors, including IR2-R, IR7-R. One of the important 
consequences of PI3K activation is to reprogram the metabolic status of the cell, such as by 
increasing glucose transporters on the cell membrane, expressing glycolytic genes, and activating 
anti-apoptotic pathways. Several studies have proposed a role of PI3K in regulating glucose 
transporter 1 in B cells and T cells by using PI3K inhibitor LY294002. The first B cell paper 
describing PI3K and surface Glut1 was published in 2006 (Doughty et al., 2006). The authors 
found that anti-Ig–induced BCR engagement increased surface Glut1 expression and uptake of 2-
[3H]deoxyglucose, which can be compromised by LY294002 inhibitor or knockout of the PI3K 
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p85α subunit. A later study used the lymphoid cell line FL5.12 to study IL-3-stimulated up-
regulation of surface Glut1 (Wieman, Wofford, & Rathmell, 2007). The authors showed that 
expression of a myristoylated and constitutively active oncogenic form of Akt is sufficient to 
maintain the level of surface Glut1 even in the absence of IL-3 stimulation. Moreover, 
expression of dominant-negative Rab11a, a Rab GTPase involved in endosomal recycling, leads 
to the accumulation of intracellular FLAG-Glut1 but reduces surface FLAG-Glut1. In sum, these 
results imply that the PI3/AKT pathway increases surface Glut1 levels through modulating the 





Figure 1.2 Metabolic re-programming during lymphocyte activation 
Naïve and memory lymphocytes are more dependent on oxidative phosphorylation than activated 
or effector cells. When naïve and memory lymphocytes are activated by antigen, they up-
regulate glucose transporter (Glut1), and hexokinase 2 (HK2), leading to higher aerobic 




1.6.7 Lis1 and dynein dependent vesicle transportation 
     Lis1 forms a complex with NUDE and NUDEL and binds the head domain of dynein heavy 
chain (most of the dyneins are microtubule minus-end motor protein) (Kardon & Vale, 2009; 
Yamada et al., 2008). There are four reported functio s of Lis1. First, at the kinetochores and 
microtubule plus ends, Lis1 forms a complex with NDEL1 and dynein. These complexes involve 
the apical movement of nerve cells and are required for proper mitotic spindle organization and 
orientation in mitotic cells (H. M. Moon et al., 2014; Shu et al., 2004; Tai, Dujardin, Faulkner, & 
Vallee, 2002). Similarly, in developing mouse embryos, Lis1 modulates centriolar microtubule 
organization and directs microtubule-associated Tiam1 to the cell cortex, which leads to local 
activation of the Rac-PAK signaling pathway. The activation of Rac-PAK establishes a polarity 
cue to guide the position of the basal body (Sipe, Liu, Lee, Grimsley-Myers, & Lu, 2013). Third, 
in postnatal hair cells, Lis1 facilitates centrosome positioning by coordinate cortical dynein and 
pericentriolar matrix organization to generate tensio  on centriolar microtubules (Sipe et al., 
2013). Finally, the interplay of Lis1, Nudel, and dynein affects the speed of minus end–directed 
cargo including lysosomes and is required for maintaining the integrity of Golgi cisternae (Liang 
et al., 2004). 
 
1.6.8 Bifurcating nutrient signaling and cell fate  
      Our hypothesis is that a lymphocyte competent to undergo differentiation unequally licenses 
its daughter cells to utilize nutrients, resulting  a bifurcation of nutritive signaling, 
transcriptional network, and cell fate (Adams et al., 2016). In one of the daughter cells, PI3K 
signaling inactivates FoxO1 by AKT-mediated phosphorylation on FoxO1 (W. H. Lin et al., 
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2015). PI3K and the mTOR pathway increase the transc iption of glucose transporter 1 (Glut1) 
and the expression of IRF4 and c-Myc. PI3K/AKT and mTOR repress autophagy, which 
facilitates mitochondrial stasis. Accumulation of aged mitochondria and up-regulated aerobic 
glycolysis synergistically increase mitochondrial ROS production (Adams et al., 2016). The loss 
of FoxO1 protection and the augmentation of IRF4 function contribute to the repression of Pax5 
or Tcf1 in one of the sibling B cells or T cells. On the other hand, one of the daughter cells has 
relatively lower PI3K activity and thus has higher AMPK activity. AMPK supports the 
translocation of FoxO1 into the nucleus and inhibits the activity of mTOCR1 (Macintyre et al., 
2014). Inhibiting mTOR stimulates autophagy, but limits glucose uptake, and represses IRF4 and 
c-Myc. This results in lower glycolysis, whereas OXPHOS and FAO both increase. Therefore, 
this daughter cell can more efficiently renew mitoch ndria and produce less mitochondrial ROS. 
Altogether, higher FoxO1 and AMPK activity and lower ROS level allow the daughter cell to 







Figure 1.3 Bifurcating nutrient signaling and cell fate 
    We proposed a model for asymmetric metabolism by si ling lymphocytes coupling 
differentiation and self-renewal. In one of the daughter cells, PI3K/AKT activates mTOR, 
glycolysis, mitostasis, and elevated ROS, but inactv tes FoxO1. Glycolytic flux and ROS are 
involved in a feedback loop that enforces the anabolic c nstellation and prepares the cells for 
rapid proliferation. Conversely, in the other sibling cell, inhibiting glycolytic flux activates 
AMPK, which shuts down glycolytic pathway genes andhelps maintain mitoclearance and 
FoxO1 activity. These interrogating feed-forward an feed-back regulations and mutual 
inhibition of other states help to bifurcate nutrient signaling in the two sibling cells and diversify 




Chapter 2: Materials and methods 
2.1 Mice 
All animal work was conducted in accordance with Institutional Animal Care and Use 
Guidelines of Columbia University. Mice were housed in specific-pathogen-free conditions. 
C57BL/6 mice, Pax5-IRES-hCD2 reporter mice (Fuxa & Busslinger, 2007), P14 TCR transgenic 
(P14) mice recognizing LCMV peptide gp33-41/Db, C57BL/6 OTII mice expressing an I-Ab-
restricted TCR specific for ovalbumin amino acids 323-339, AMPKα1 knockout mice 
(Jorgensen et al., 2004) (Prkaa1tm1Vio), and IRF4 knoc out mice (Klein et al., 2006) have been 
previously described. 8-12 week old mice were used for most experiments. Myc-tagged-Glut1 
mice were from Dr. Jeffery Rathmell (Young et al., 2011), whereas Glut1fl/fl mice were from Dr. 
Gerard Karsenty (Wei et al., 2015). 
 
2.2 Cell culture and lymphocyte activation 
Spleens from mice were isolated and processed usinge tablished protocols. B cells and CD8+ T 
cells were enriched from spleens by magnetic bead ngative selection with the MACS B cell 
isolation kit (Miltenyi) and the MACS CD8+ T cell isolation kit (Miltenyi), respectively. B cells 
(5 x 105 cells per well in a 48-well plate) were cultured in Iscove’s (Corning) complete media, 
unless specified otherwise, with lipopolysaccharide (LPS) (20 µg/mL; InvivoGen) for up to three 
days. Enriched CD8+ T cells (5 x 105 cells per well) were cultured in Iscove’s complete m dia 
containing human recombinant IL-2 (100 units/mL) in 48 well plates coated with anti-CD3/anti-
CD28 antibodies (1 µg/mL; Bio X Cell). For stimulation of CD8+ T cells from P14 mice, single 
cell suspensions from whole spleens were prepared and cultured in Iscove’s complete media, 
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unless specified otherwise, containing gp33-41 peptid  (1µg/mL) plus IL-2 (100 units/mL). For 
glucose deprivation experiments, B cells or P14 CD8+ T cells were cultured in glucose-free/2mM 
glutamine replete RPMI (Gibco) supplemented with Fetal Calf Serum (dialyzed overnight with 
SnakeSkin dialysis tubing 10K MWCO; Thermo Fisher) and where specified 10 mM D-(+)-
glucose (Sigma) or 10 mM D-(+)-galactose (Sigma). The following compounds were used in cell 
culture experiments: mDivi-1 (Cayman), Chloroquine (Enzo), Metformin (AMPK activator; 
Calbiochem), Rapamycin (mTOR inhibitor; Selleckchem), N-Acetyl-L-cysteine (NAC; Sigma), 
2-Deoxy-D-glucose (2-DG; Sigma), LY294002 (PI3K inhibitor; Cell Signaling), Triciribine 
(AKT inhibitor; Cayman), AS1842856 (FoxO1 inhibitor; Calbiochem), and Oligomycin (Sigma). 
 
2.3 Retroviral transduction 
Enriched B cells or CD8+ T cells were stimulated with LPS or plate-bound anti- 
CD3/anti-CD28 antibodies plus IL-2, respectively, for 36 hours prior to retroviral transduction. 
Cells were then re-plated in supernatant collected prior to transduction. Retroviral constructs 
used were as follows: mCherry-alpha-tubulin fusion protein (Day et al., 2009); mouse dominant 
negative Drp-1 (K38A), a gift from David Chan (Addgene plasmid # 26049) that we 
subsequently cloned into the MSCV-IRES-Thy1.1 plasmid, a gift from Anjana Rao (Addgene 
plasmid # 17442); and hexokinase 2, made by subcloning the rat hexokinase 2 coding sequence 
into an MSCV-IRES-GFP vector. Empty MSCV-IRES- Thy1.1 or MSCV-IRES-GFP vectors 
were used as controls. The pMIG-IRES-truncated human NGFR and its derivative exofacial-
FLAG epitope tagged rat Glut1 were gifts from Dr. J. Rathmell (Wieman et al., 2007); GFP-
wild-type Rab11a  and GFP-dominant negative Rab11a (S25N) were made by subcloning human 
Rab11a (Addgene plasmid #s 12674 and 12678, respectively) (Choudhury et al., 2002) into the 
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MSCV-IRES-Thy1.1 vector; and Far Red-tubulin by subcloning pmiRFP703-Tubulin (Addgene 
plasmid # 79991) into the MSCV-IRES-Thy1.1 vector. Empty MSCV IRES- Thy1.1 or MSCV-
IRES-truncated NGFR (Addgene plasmid # 27489) vectors were used as controls. 
 
2.4 Adoptive Transfers and Infectious Challenges 
Resting CD8+ T cells from P14 mice (Thy1.1+) were purified with the CD8+ T Cell Isolation Kit 
(Miltenyi Biotec). 3 × 106 CD8+ T cells and adoptively transferred intravenously (i.v.) into wild-
type congenic C57BL/6 mice (Thy1.2+). To generate acutely resolved systemic infections, mice 
were infected with 5 × 103 PFUs of Listeria monocytogenes expressing gp33-41 (LMgp33) by 
intravenous injection. The animals were sacrificed by day 4 post-infection for sorting of CD8+ 
Thy1.2- cells for immunofluorescence.  
        For surface Glut1 level experiments, P14 Myc-Tagged Glut1 transgenic mice were infected 
with 2 × 105 plaque-forming units (PFUs) of LCMV, Armstrong strain, by intraperitoneal (i.p.) 
injection. The animals were sacrificed by day 7 post-infection for FACS analysis.  
 
2.5 Flow cytometry 
For detection of intranuclear/intracellular antigens, cells were initially washed in PBS and 
stained by antibody against selected surface antigens and by LIVE/DEAD Fixable Green or Red 
Dead Cell Stain Kit (Thermo Fisher) and then treated with the Transcription Factor Buffer 
Staining Set (eBioscience) according to the manufact rer’s instructions. Antibodies specific for 
the following antigens were used: Pax5 (clone 1H9 conjugated to Alexa Fluor 488 or PerCP-
Cy5.5 from Biolegend or APC from eBioscience; 1:200), IRF4 (clone 3E4 conjugated to PE or 
eFluor660 from eBioscience; 1:100), TCF1 (clone C63D9 conjugated to Alexa Fluor 647 from 
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Cell Signaling; 1:100), GFP (clone 9F9.F9 conjugated to Alexa Fluor 488 from Sigma; 1:100), 
and Thy-1.1 (clone OX-7 conjugated to PerCP-Cy5.5 from Biolegend; 1:200). BD LSRII, 
Fortessa, and FACSAria II flow cytometers with FACSDiva software were used to analyze 
and/or purify cells. Flow cytometry data was analyzed using FlowJo software (versions 8 and 10). 
 
2.6 Other dye staining protocols 
     Mitochondrial membrane potential was measured by incubating cells with MitoTracker® Red 
CMXRos (Cell Signaling) (100nM for flow cytometry; 200nM for confocal microscopy) for 15 
to 20 minutes in the culture medium at 37 degrees Cel ius. Autophagic organelles were labeled 
with CYTO-ID Autophagy Detection Kit (Enzo; 1:1000 dilution of stock) according to the 
manufacturer’s instructions. Reactive Oxygen Species (ROS) were detected by incubating cells 
with MitoSOX Red Mitochondrial Superoxide Indicator (Thermo Fisher; 5 µM) for 15 minutes 
at 37 °C in media or CM-H2DCFDA (Thermo Fisher; 5 µM) for 30 minutes at 37 °C in media. 
Glucose uptake was measured by incubating cells in 2-NBDG (Cayman; 100 µM) for 45 minutes 
at 37 °C in glucose-free media. 
 
2.7 Confocal microscopy 
Confocal microcopy was performed as described (J. T. Chang et al., 2011; W. H. Lin et al., 
2015). Using transmitted light morphology, tubulin bridge staining, and DNA staining, specific 
identification of telophase or cytokinetic sibling pairs with exclusion of any spurious 
neighboring-but-unrelated cell pairs is achieved (Lin et al., 2015). For fixed cell imaging, cells 
were adhered to poly-l-lysine (Sigma) coated coverslips (#1.5 Thermo Fisher) and treated with 
freshly prepared 3.7 % PFA (Sigma) diluted in cell u ture media (pH 6.8) in order to preserve 
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mitochondrial morphology and MitoTracker Red FM fluorescence intensity. Following brief 
treatment with 0.1% Triton, cells were stained with antibody against α-Tubulin (clone YOL1/34 
Abcam; 1:300) and then anti-rabbit antibody conjugated to Alexa Fluor 568 (Thermo Fisher) in a 
PBS solution containing 0.01 % saponin and 0.25 % fish skin gelatin (Sigma). For live cell 
imaging, cells were transferred to poly-l-lysine coated 8 chambered coverglass wells (#1 LabTek) 
in warm cell culture media and allowed to adhere bri fly before imaging. Images were acquired 
on inverted confocal microscopes (Zeiss LSM710 or Nikon Ti Eclipse) and processed 
using ImageJ (v.1.46r) or Fiji (v.2.0) software to pr ject z stacks, apply a minimal smooth filter 
for some displayed images, rotate, change pseudocolors, convert to RGB, and add scale bars or 
time scales. Total fluorescence in defined regions of single cells was quantitated using the 
integrated density function in ImageJ. 
 
2.8 Statistical Analyses 
Significance between experimental groups was determin d using two-tailed t tests or two-tailed 
ratio t tests for paired data, two-tailed Mann-Whitney test for unpaired data, or repeated-
measures one-way ANOVA. Two-tailed Fisher’s exact tes was used to determine significance 
for contingency statistics of microscopy data comparing asymmetric versus symmetric 
fluorescence intensity of molecules between sibling pairs. Statistical analyses and summary 
statistics to determine means and SDs were carried out using GraphPad Prism software v. 7 (∗p < 




Chapter 3: Asymmetric mitochondrial stasis in daughter cells guides the 







The results in this chapter have been published in a co-first author paper:  
 Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation  
 over Self-Renewal. 
Adams WC, Chen YH, Kratchmarov R, Yen B, Nish SA, Lin WW, Rothman NJ, 
Luchsinger LL, Klein U, Busslinger M, Rathmell JC, Snoeck HW, Reiner SL. 




3.1 Pax5 repression represents an irreversible commit ent to differentiation 
      After immunization, Pax5-positive B cells undergo cl nal selection, and generate  
two exclusive cell populations: Pax5 high B cells and terminally differentiated, Pax5–silenced 
plasma cells. Using cells from Pax5-IRES-human CD2 reporter mice (Fuxa & Busslinger, 2007), 
we performed a re-plating assay to compare the ability of hCD2 (Pax5)hi and hCD2 (Pax5)low 
cells to self-renew and differentiate. Splenic B cells labeled with cell proliferation dye were 
activated with LPS. In cells having undergone several rounds of division, hCD2hi and hCD2low 
cells were sorted by flow cytometry and re-plated in LPS-containing media. The results showed 
that hCD2 (Pax5)hi cells are capable of generating both Pax5hi progeny (self-renewal) and of 
giving rise to Pax5low progeny, whereas Pax5(hCD2)low cells are unable to regain Pax5 
expression and thus are only capable of giving rise to Pax5low progeny (Figure 3.1). These results 
suggest the Pax5 population, or a subset of this population, has stem-cell like activity: self-







Figure 3.1 Pax5 repression represents an irreversible commitment to differentiation 
(Left) LPS-activated, Pax5 (hCD2) reporter B cells were sorted by flow cytometry from later cell 
generations based on surface hCD2 expression. Post-sort purity of live cells is shown.  
(Right) Pre-sort Pax5 protein staining of fixed cells next to Pax5 protein staining of sorted cells, 
followed by Pax5 protein staining of sorted populations one day after re-plating in fresh media 
containing LPS. Plots depict one representative experiment and numbers are summary statistics 




3.2 Pax5 repression is accompanied by reduced mitochondrial membrane potential 
A successful immune response depends on the generatio  of effector and memory 
lymphocytes to provide disease-fighting cells as well as immunological memory. However, the 
detailed mechanism by which the balance of these two populations is maintained remains unclear. 
Our laboratory’s earlier work supports a stem-cell model of clonal selection. That is, after 
antigen activation, an activated lymphocyte (such as a GC B cells or an activated memory cell) 
can generate differentiated effector and self-renewal progenitors at the same time through 
asymmetric cell division. Our earlier work has found that in dividing B cells and T cells, the two 
daughter cells asymmetrically express the lineage-maintaining transcription factors Pax5 and 
Tcf1, respectively (W. H. Lin et al., 2015). However, the detailed mechanism by which the 
polarized signal is provided remains unclear. 
      Effector and memory lymphocytes have been foud to adopt distinct metabolic preferences. 
Also, mitochondrial dynamics and functional statuses have been linked to the differentiation of 
plasma cells. I hypothesis that asymmetric mitochondrial functional status in the two daughter 
cells provides guiding signals for establishing the asymmetric transcriptional program. To 
understand whether transcription programming is couple to mitochondrial status, I performed 
FACS analysis combining cell proliferation dye MitoTracker Red CMXRos (Mito-CMX), IRF4 
or Pax5 specific antibodies, and mitochondrial membrane potential-dependent dye. To 
demonstrate that the staining of Mito-CMX is dependent on mitochondrial membrane potential, I 
performed Mito-CMX staining on activated B cells incubated with various concentrations of 
mitochondrial membrane potential uncoupler, carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP). FACS analysis showed that Mito-CMX staining is inversely correlated with the 
concentration of CCCP in the media (Figure 3.2A), suggesting that the staining of Mito-CMX is 
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positively associated with mitochondrial membrane potential. When combining Mito-CMX 
staining with Pax5 and IRF4 staining, we found thate IRF4hi population has relatively lower 
Mito-CMX staining, whereas the IRF4 intermediate population has higher Mito-CMX staining 
(Figure 3.2 B Left). Moreover, Mito-CMX high and IRF4 intermediate B cells are mainly Pax5 
high, whereas Mito-CMX low and IRF4 high cells are Pax5 low (Figure 3.2 B Right). Taken 
together, these results suggest that Pax5 high, IRF4 intermediate subsets have relatively higher 
mitochondrial membrane potential, whereas more differentiated plasma blasts (Pax5 low, IRF4 
high) exhibit reduced mitochondrial membrane potential. Gating on the number of cells division, 
we found that after B cells are activated, Pax5 is up-regulated together with increased 
mitochondrial membrane potential in the first two divisions. After the third division, subsets of 
cells start to down-regulate Pax5 and mitochondrial membrane potential. The reduction of 
mitochondrial membrane potential is more obvious in the Pax5 low population than in the Pax5 





Figure 3.2 Pax5 repression is accompanied by reduction of mitochondrial membrane 
potential. 
(A) A control experiment to demonstrate MitoTracker CMXRos dye (MitoCMX) staining is 
positively correlated with mitochondrial membrane potential. B cells were stimulated with LPS 
for 1.5 days. Before FACS analysis, CCCP was added into the media at indicated concentrations 
for 30 minutes, and then MitoTrackerCMXRos was added 20 minutes before FACS analysis.  
(B) CTV-labeled B cells were stimulated with LPS for 3.5 days and stained with MitoTracker 
CMXRos dye (MitoCMX) to measure mitochondrial membrane potential. Left plot: IRF4 versus 
MitoTracker CMXRos. Right plot: two populations of cells based on levels of IRF4 and 
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MitoTracker CMXRos dye (Mito) were analyzed for cell division versus Pax5. 
(C) CTV-labeled naïve B cells stimulated with LPS for 3.5 days and stained with MitoTracker 
CMXRos dye (MitoCMX) to measure mitochondrial membrane potential. The plots are gated on 





3.3 Differential mitochondrial membrane potential in sibling cells is independent of cell-cell 
interaction  
After observing the association of Pax5 expression and mitochondrial membrane potential, I 
aimed to visualize the dynamics of total mitochondria and mitochondrial membrane potential 
during each stage of cell division. In LPS-stimulated B cells, mitochondria are distributed around 
the two microtubule-organizing centers (MTOCs) in metaphase cells, whereas they are 
accumulated in the middle of division plane in anaphase. I found that sibling cells exhibit 
differential mitochondrial membrane potential in the cytokinetic stage, although the total amount 
of mitochondria is relatively equally distributed between the sibling cells (Figure 3.3 A). 
Staining for the mitochondrial outer membrane protein Tom20 reveals that the sibling cells that 
have lower mitochondrial membrane potential still have mitochondria, suggesting that the lower 
Mito-CMX staining in one of the sibling cell is not bserved because of that sibling cell lacking 
mitochondria. 
     In our previous studies, we have found two groups of transcription factors that require 
different mechanisms to establish asymmetric patterns. The first group of transcription factors 
requires extrinsic signals for establishing polarity in cytokinetic cells. For examples, the 
asymmetric pattern of Bcl6 depends on cell-cell interaction through ICAM. These transcription 
factors are polarized in metaphase and exhibit asymmetric accumulation in sibling cells in vivo. 
However, they lose their asymmetric pattern and become equally distributed between the 
daughter cells when lymphocytes undergo homeostatic expansion in Rag1 knockout mice 
(Barnett et al., 2012). Because unequal mitochondrial membrane potential can be observed in 
LPS-stimulated B cells, I hypothesized that there is an intrinsic mechanism that is capable of 
establishing and maintain asymmetric mitochondrial st tus in sibling cells. If the hypothesis held, 
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I expected that differential mitochondrial membrane potential in sibling cells could be observed 
under a homeostatic expansion condition. The result of confocal analysis of transferred B1-8 
high B cells to Rag1 knockout animals is in alignmet with this prediction. That is, unequal 
mitochondrial membrane potential in sibling cells can still be observed during homeostatic 








Figure 3.3 Sibling cells exhibit different mitochondrial membrane potential independent of 
cell-cell interaction  
 (A) Dynamics of mitochondria during B cell divisions. B cells were stimulated with LPS 
(20ug/ml) for 40 hours. The cells were stained with MitoTracker CMXRos dye (CMXRos) 
for 20 minutes before cell sorting, and then were fix d with 4% paraformaldehyde and 





protein Tom20. The figures show representative events for metaphase (n=10), early 
anaphase (n=5), late metaphase (n=5) and telophase cell  (n=12). 
(B) MitoTracker CMXRos staining of homeostatically proliferating B cells (B1-8hi, CD45.1+) 
adoptively transferred into Rag1 knockout mice. By da  5 post-transfer, CD45.1+ cells are 
sorted for confocal analysis. Total number of imaged cytokinetic cells is 29. 
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3.4 Pax5 and healthy mitochondria are evident in the same daughter cell 
        To understand the dynamic relationships betwe n Pax5 and mitochondrial membrane 
potential in dividing cells, in vitro stimulated B cells were co-stained with MitoTracker Red 
CMXRos dye and Pax5 and then subjected to confocal analysis. I found that the sibling cells 
with asymmetric Pax5 also exhibited greater differences in mitochondrial membrane potential, 
although sibling cells with different mitochondrial membrane could be observed in sibling cells 
with symmetric levels of Pax5 (Figure 3.4). The segregation pattern of Pax5 and mitochondria 
with higher membrane potential suggests that the daughter cells exhibit different mitochondrial 
activity before the establishment of asymmetric Pax5, nd that the sibling cells with lower Pax5 
levels also have a relatively lower mitochondrial proton gradient. Strong MitoTracker Red 
CMXRos dye staining is associated with three factors: g eater mitochondrial membrane potential, 
higher OXPHOS activity, and higher mitochondrial mass. Because Tom20 staining reveals that 
the total mitochondrial mass is relatively equal in sibling cells with differential mitochondrial 
membrane potential (Figure 3.3), it is more likely that the sibling cells with lower Pax5 exhibit 
lower mitochondrial activity. There are two mechanisms resulting in low mitochondrial activity. 
First, aged, malfunctioning mitochondria have lower membrane potential, and thus they are 
removed by the Pink/Parkin pathway. Second, lower mitochondrial membrane potential may 
suggest the cells are less dependent on OXPHOS as an energy source and may be fueled by other 






Figure 3.4 Pax5 and healthy mitochondria fall in the same daughter cell.  
    The cultured B cells were first labeled with MitoCMXRos for 20 minutes in the media before 
being harvested for methanol fixation. The samples w re fixed with 3% PFA diluted in PBS, and 
then were permeabilized with methanol. After fixation, Pax5 protein was stained with rabbit 
anti-mouse Pax5 monoclonal antibody and goat-anti-rbbit IgG conjugated to Alexa Fluor® 647 
dye. The tubulin was stained with rat monoclonal Tubulin antibody [YOL1/34] and goat-anti-rat 
IgG conjugated with Alexa Fluor® 488 dye.  The number of imaged cytokinetic events is 41 




3.5 MitoTracker Pulse assay identifies unequal mitochondrial clearance in cytokinetic cells 
     Maintaining healthy mitochondria has been linked to maintaining self-renewal ability and to 
preventing senescence of various type of stem cells, including muscle stem cells, neural stem 
cells, and cancer stem cells (Garcia-Prat et al., 2016; Katajisto et al., 2015; Khacho et al., 2016). 
Two different mechanisms have been reported for maintaining mitochondrial health in stem cells. 
One of the mechanisms is removing malfunctioning mitochondria through autophagy or 
mitophagy. This mechanism is found in muscle and neural stem cells (Garcia-Prat et al., 2016; 
Khacho et al., 2016). By contrast, studying the stem-like cells in a breast cancer cell line reveals 
daughter cells may inherit unequal amount of aged mitochondria, thus affecting their stem-like 
properties (Katajisto et al., 2015). 
     To determine whether these two mechanisms explain the asymmetric mitochondrial 
membrane potential phenotype in dividing B cells, we performed a MitoTracker Pulse assay to 
visualize the dynamics of clearing or accumulation of aged mitochondria. Imaging fixed cells by 
confocal microscopy reveals that in dividing lymphocytes, the subcellular distribution of aged 
(pulsed) mitochondria is fairly symmetric in metaphse until early telophase. However, when 
cells enter the cytokinetic stage, we find that in more than half of the sibling pairs, different 
amounts of aged (pulsed) mitochondria are inherited (Figure 3.5 A). 
The same trend can also be observed in live cell imaging, implying that the observed 
differential accumulation of labeled mitochondria in one of the sibling cells is not due to an 
artifact of staining. Live cell imaging of anaphase cells or early cytokinetic cells reveals that the 
labeled mitochondria do not accumulate in a particular single daughter cell (Figure 3.5 B). Also, 
aged (pulsed) mitochondria do not exhibit a unidirect onal movement pattern in time-lapse 
videos (Figure 3.5 B). However, unequal amounts of aged (pulsed) mitochondria can be 
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observed in late cytokinetic sibling cells (Figure 3.5 C). In sum, these data are more supportive 
of the hypothesis that asymmetric mitochondrial status is due to unequal ability to remove or 











Figure 3.5 MitoTracker Pulse assay identified unequal mitochondrial clearance in 
cytokinetic cells. (A) Later in division, mitochondrial clearance is unequal. MitoTracker Red 
FM (MTR)-pulsed, LPS-stimulated B cells were fixed after 44 hours and stained with DNA dye 
(DAPI) and anti-tubulin antibodies. The plots show representative examples of metaphase, 
telophase, and cytokinetic cells. Experiment repeated three times (metaphase: n=11 cells, 
telophase: n=8 sibling pairs, and cytokinesis: n=18 sibling pairs). Graph depicts percentage of 
sibling cell pairs with equal or unequal ratios of 3D intensity of MTR and tubulin (*P<0.05, 
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Fisher's exact test). (B) Two representative time-lapse series of LPS-stimulated B cells labeled 
with SiR-tubulin dye (350nM, 15 hours) and pulsed with MTG (100nM). Frames represent 3-
minute intervals. Scale bars = 6 mm. (C) A representative time-lapse series of LPS-stimulated B 
cells transduced with mCherry-alpha-tubulin RV and pulsed with MTG 16 hours prior to 




3.6 Inhibition of mitochondrial fission-induced effector cell differentiation 
     To study the effect of accumulation of aged mitochondria, we compared the effect of several 
mitochondrial inhibitors, which target different mitochondrial pathways, on the dynamics of 
mitochondrial morphology and on the transcriptional program of activated B cells. First, we 
treated the activated B cells with different inhibitors, and then labeled the total mitochondrial 
network with MitoTracker Green dye, which is a mitoch ndrial membrane potential-independent 
dye. 
The results showed that rotenone, which is an inhibtor of electron transport form complex I 
to ubiquinone, did not significantly affect mitochondrial mass in treated B cells (Figure 3.6). By 
contrast, CCCP, which is a mitochondrial oxidative phosphorylation uncoupler, reduced the 
mitochondrial mass, which is in accordance with previous report suggesting that depolarized 
mitochondria are cleared by a mitophagy mechanism (D. Narendra et al., 2008). mDivi-1, which 
is a mitochondrial fission inhibitor, increased MitoTracker Green staining , suggesting inhibiting 
mitochondrial division extends the mitochondrial network and increases the total mitochondrial 
mass (Cassidy-Stone et al., 2008). 
      Activated B cells are characterized by high expr ssion of Pax5 and B220, but low expression 
of CD138, Embigin, and IRF4. By contrast, plasma cells exhibit low levels of B220 and Pax5 but 
high levels of intracellular IRF4, and surface CD138 and Embigin (Fairfax, Kallies, Nutt, & 
Tarlinton, 2008; Kallies et al., 2007). Our previous work has established that PI3K inhibitor 
LY297004 suppresses the differentiation of plasma cells, whereas Foxo1 inhibitor induces 
differentiation toward plasma cells (W. H. Lin et al., 2015). By comparing the surface marker 
and intracellular transcription factor patterns, we found that mDivi-1 has a similar effect to 
Foxo1 inhibitor, whereas rotenone works like PI3K inhibitor. The CCCP-treated cells acquired 
69 
 
an intermediate phenotype, in which IRF4 and Embigin were upregulated but the down-
regulation of Pax5 and B220 were inhibited (Table 1). These results suggest that inhibition of 
complex I in the electron transport chain has a similar effect to repressing PI3K, and that 
inhibition of mitochondrial fission mimics the effect of inactivating Foxo1 to stimulate 
differentiation into effector cells. 
           What is the result of inhibiting mitochondrial fission? We established a FACS staining 
protocol, called “mitoclearance”, combining MitoTracker Green pulse, cell proliferation dye and 
MitoSox staining. MitoTracker Green is a mitochondria-specific dye whose staining is less 
affected by mitochondrial membrane potential. MitoSOX is a mitochondria-specific superoxide 
detection reagent, whose oxidized products become fluorescent when binding to nucleic acid. 
The dilution of cell proliferation dye is mainly dep ndent on cell division, whereas the dilution 
of pulsed MitoTracker Green reflects both dilutions during cell division and clearance of labeled 
mitochondria. We found that cells exhibiting high MitoSOX staining retained more MitoTracker 
Green staining (mitoclearance low), whereas MitoSox low cells are a mixture of mitoclearance 
high and low cells. The MitoSox low and mitoclearance low cell may represent the cells that 
have repaired their aged mitochondria by fusion with new mitochondria (Figure 3.7). 
       Using the “mitoclearance” assay, we can see that mDivi-1-treated cell retained more aged 
mitochondria with MitoTracker Green pulse compared with the no drug control group (Figure 
3.8 upper row). Also, MitoSox staining showed that mDivi-1 treatment produced more 
mitochondrial ROS. Taken together, the results suggest accumulation of aged mitochondria may 
enhance mitochondrial superoxide production (Figure 3.8 lower row). 
  To rule out the possibility that the observed effect of mDivi-1 on the differentiation of 
lymphocytes is the off-target effect of mDivi-1, we directly tested the result of disrupting Drp-1 
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function by over-expression of dominant negative Drp-1 (K38A) (DN Drp-1) using retroviral 
vector to transduce activated lymphocytes. FACS analysis showed that overexpression of DN 
Drp-1 has an even stronger effect on repressing Pax5 (and stimulating IRF4 expression) in B 
cells (Figure 3.9 A), and more obviously, Tcf1 repression in CD8+ T cells (Figure 3.9 B). 
Moreover, the effect of overexpression of DN Drp-1 can be partially rescued by the addition of 
N-Acetyl L-Cysteine (NAC), a ROS scavenger, in the m dia, suggesting that the over-served 
repression effect involves the production of ROS (Figure 3.9 C) 
     In T cells, mitochondrial ROS has been reported to play a critical role in stimulating 
transcription factor nuclear factor of activated T cells (NFAT) and support interleukin-2 (IL-2) 
production (Sena et al., 2013). Here, our findings support the idea that mitochondrial ROS also 
plays a role in the repression of lineage-maintaining transcription factors in B cells and T cells, 











Figure 3.6 Mitochondrial fission inhibitor mDivi-1 treatment increased mitochondrial mass 
     B cells derived from wild-type B6 mice were stimulated with LPS (20ug/ml) for 3 days. The 
inhibitors were added (10µM mDivi-1; 2.5µM CCCP; 300nM Rotenone) into the culture media 
for 4 hours before live cell imaging by scanning microscopy. MitoTracker Green, which is a 





Table 1 The effects of drugs on B cell transcriptional program and mitochondria 
membrane potential.  
      B cells were activated with LPS (20µg/ml), and drugs were added at the beginning of the 
culture (CCCP: 1.5µM, mDivi-1: 10µM, Rotenone: 150nM, PI3K inhibitor LY294002: 0.5µM, 
Foxo1 inhibitor AS1842856: 1µM). MitoTracker CMXRos was added to the media (200nM) 20 
minutes before cells were harvested for FACS analysis.  










IRF4 Low Hi Up Up Down Down Up 
Pax5 Hi Low Retain hi Down Retain hi Retain hi Down 
B220 Hi Low Retain hi Down Retain hi Retain hi Down 
CD138 Low Hi - - Down Down Up 
Embigin Low Hi Up +/- - Down Up 





Figure 3.7 Mitochondrial stasis is associated with mitochondrial ROS production 
MitoTracker GreenFM pulse-labeled B cells were activated with LPS for 3 days and then stained 
with MitoSOX. Cell division versus MitoSOX fluorescence in non-MitoSOX-labeled control 
cells (far left) versus MitoSOX-labeled cells (second-to-left). Cell division versus mitoclearance 
of MitoSOXhi cells and MitoSOXlo cells (third column), compared to all cells (far right) 
illustrates that MitoSOXhi cells are enriched with stasis of aged (pre-pulsed) mitochondria, 
analogous to differentiated effector T cells enriched with mitochondrial stasis. Data are 






Figure 3.8 Inhibition of mitochondrial fission impedes mitochondrial turnover and 
increases mitochondrial ROS. 
(Upper row) FACS of CTV-labeled and MitoTracker Green FM ("MTG") pulse-activated B cells 
(top row) and CTV-labeled and MitoSox labeled B cells (bottom row) stimulated with LPS for 
66 hours. Cells were cultured in the absence or presence of mDivi-1 (10μM). A reverse arrow on 
the y-axis indicates dilution (and/or elimination) of pre-labeled (pulsed) mitochondria that occurs 
with each cell division (x-axis), termed mitoclearance. Upper row statistical gr phs display the 
frequency of cells within the entire trapezoidal MTG low gate (left) and MFI of MTG signal in 
the fourth cell division (right) (n=3, **P<0.01 and ***P<0.005 for indicated treated groups 
compared to no drug control group, one-way repeated m asures ANOVA).  
(Bottom row) CTV-labeled B cells stimulated with LPS in the absence or presence of mDivi-1 
(10 μM) and analyzed on day 3 for cell division versus mitochondrial ROS (MitoSOX). 
Horizontal numbers denote the frequency of cells within a bound area. Vertical numbers denote 
mean fluorescence intensity (MFI) of all cells, notsimply those within bound area. Bottom row 
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statistical graphs display frequency of MitoSOXhi cells (left) and MitoSOX MFI (right) among B 
cells stimulated in the absence or presence of mDivi-1 (n=3, *P<0.05 or **P<0.01, two-tailed 









Figure 3.9 Overexpression of dominant negative Drp-1 promotes effector cell 
differentiation. (A) Overexpressing dominant negative Drp-1 (DN Drp-1) by transducing the B 
cells with retrovirus up-regulated IRF4 but repressed Pax5. B cells were activated with LPS for 
40 hours, and then infected with retrovirus carrying DN Drp-1 or control vector, and then re-
plating for another 24 hours before FACS analysis.  
(B) Overexpressing dominant negative Drp-1 (DN Drp-1) by transducing the CD8+ T cells with 
retrovirus repressed Tcf1. CD8+ T cells enriched from spleen of wild-type B6 mice by MACS kit 
selection were activated by plate bound anti-CD3 and anti-CD28 and IL-2 (100 units/ml) for 40 
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hours, then infected with retrovirus carrying DN Drp-1 or control vector, and then re-plated in 
the presence of anti-CD3, anti-CD28, and IL-2 for another 24 hours before FACS analysis.  
(C) The addition of N-Acetyl L-Cysteine (NAC) (3mM) in the culture media suppressed the 
repression effect of DN Drp-1 on Pax5 and Tcf1 in B cells and T cells, respectively. Data are 




3.7 Inhibiting mitochondrial biogenesis and renewal promotes effector cell differentiation 
Mitochondria quality control involves four major stages: fission, turnover, fusion, and 
biogenesis. So far, we have demonstrated that accumulation of aged mitochondria that produce 
more mitochondrial ROS accelerated the differentiation into effector cells by perturbing the 
fission and turnover mechanism. Next, I examined th effect of disrupting the key factors in the 
biogenesis pathway. If our model that accumulating aged mitochondria serves as the trigger for 
effector cell differentiation held, I expected that inhibiting biogenesis of mitochondria should 
accelerate the differentiation of effectors but reduce the population of self-renewing cells.  
     Two major transcription factor families that contribute to the biogenesis of mitochondrial 
genes are FoxO and PGC-1α (peroxisome-proliferator-activated receptor γ co-activator-1α). 
FoxO family transcription factors (especially FoxO1 and FoxO3) have been reported to 
participate in the biogenesis of mitochondria (Cheng t al., 2009; Peck, Ferber, & Schulze, 2013; 
Philip-Couderc et al., 2008). As previously discussed in the introduction section, the activity of 
Foxo1 can be inhibited by AKT-mediated phosphorylation. PGC-1α serves as co-transcriptional 
regulation factor modulating the activity of other key transcription factors, including nuclear 
respiratory factor 1 and nuclear respiratory factor 2, involved in mitochondrial gene biogenesis 
(Jornayvaz & Shulman, 2010). One of the key regulators of PGC-1α is AMPK (AMP-activated 
protein kinase). AMPK is a sensor of several stress signals, including low ATP level, ROS, nitric 
oxide, and reactive nitrogen species (RNS) (Cardaci et al., 2012). For mammalian cells, AMPK 
is a heterotrimeric complex comprised of α, β, and γ subunits. Each subunit has multiple 
isoforms (α1, α2, β1, β2, γ1, γ2, and γ3) and their expression is tissue- and cell-type-specific. For 
lymphocytes, α1 is the only α subunit expressed in B cells and T cells (Mayer, Denanglaire, 
Viollet, Leo, & Andris, 2008; Tamas et al., 2006). 
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      We therefore tested whether knocking out the AMPK α1 subunit and treating cells with 
FoxO inhibitor would accelerate effector cell differentiation. Comparing the B cells derived from 
an AMPKα1 knockout animal to those from a wild-type animal, we found that more B cells 
exhibit a Pax5-low phenotype in the later divisions a d that the Pax5 inhibition effect of the 
FoxO inhibitor and mDivi-1 is more significant in the AMKPα1 knockout (Figure 3.10). A 
similar synergistic effect of FoxO inhibitor and mDivi-1 on Tcf1 repression was also observed in 
AMPKα1 knockout CD8+ T cells by using CD4-Cre to conditionally delete AMPKα1 in T cells 








Figure 3.10 Inhibiting mitochondrial biogenesis and renewal synergistically promotes 
effector cell differentiation. 
Cell division versus Pax5 expression of CTV-labeled B cells from wild-type and AMPKα1 
knockout mice stimulated with LPS for 3 days in theabsence or presence of mDivi-1 (10 µM), 
FoxO1 inhibitor (1µM), or both inhibitors. Graph contains frequency of Pax5hi cells in the last 
cell division among conditions indicated (n=3, *P<0.05 or **P<0.01 or ***P<0.005 comparing 
groups with one or more perturbations to group with no perturbation, repeated measures one-way 




Figure 3.11 Inhibiting mitochondrial biogenesis and fission promotes effector cell 
differentiation. CD8+ T cells were enriched from wild-type or CD4-Cre+ animals with either 
loxP sites flanked Glut1 or wild-type Glut1 allele. Isolated CD8+ T cells are labeled with cell 
proliferation dye (CTV) and then stimulated by plate-bound anti-CD3 and anti-CD28 in the 
presence of IL-2 in the culture media. Cells were harvested for FACS staining. The plots are 














4.1 Aerobic Glycolysis Linking an Anabolic Constellation to Differentiation 
 
     So far, our results suggest that the differing abilities of the two daughter cells to clear aged 
mitochondria is linked to the fate determination of effector cells and maintenance of self-renewal 
ability. We also demonstrated that accumulation of aged mitochondria results in augmentation of 
mitochondrial ROS production. Mitochondrial aging is associated with ROS induced-damage to 
proteins and mitochondrial DNA, which results in mitochondrial dysfunction (Cui, Kong, & 
Zhang, 2012). Why do activated lymphocytes generate high amounts of ROS? This is associated 
with the pathway that they use to produce energy. Resting and naïve lymphocytes and memory 
cells produce energy mainly through oxidation phosprylation, whereas activated lymphocytes 
and effector cells produce energy by aerobic glycolysis and oxidation phosphorylation (C. H. 
Chang et al., 2013; Palmer, Ostrowski, Balderson, Christian, & Crowe, 2015; T. Wang, 
Marquardt, & Foker, 1976). After activation, both B cells and T cells display an augmented 
extracellular acidification rate (ECAR), which reflects aerobic glycolysis, and an augmented 
oxygen consumption rate (OCR), which represents mitochondrial respiration function 
(Caro-Maldonado et al., 2014). The self-reinforcing relationship between mitochondrial stasis 
and ROS prompted us to test the effects of metabolism on lymphocyte differentiation. 
      To clarify the relationships between glucose utilization and lymphocyte differentiation, we 
tested the result of perturbing the glycolytic pathway on the transcriptional program of B and T 
lymphocytes. Inhibiting glycolytic flux by treating activated lymphocytes with 2-Deoxy-D-
glucose (2-DG) suppressed the downregulation of Pax5 and Tcf1 in proliferating B cells and T 
cells, respectively (Figure 4.1). That is, inhibition of glycolysis shifted the balance of 
lymphocyte fate toward self-renewal but suppressed effector cell differentiation. Indeed, 2-DG 
treatment has been reported to enhancing memory T cell formation in vivo by sustain FoxOx1 
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and Tcf1 activity(Sukumar et al., 2013).  
     In addition, 2-DG treatment also reduced the proliferation rate (Figure 4.1 A). Therefore, it is 
possible that the suppression of Pax5 and Tcf1 down-regulation is partially contributing to the 
reduced number of cell divisions. Thus, I tried to perform an opposite experiment to enhance 
glycolysis. If glycolysis is linked to effector cell differentiation, we predicted that enhancing 
glycolysis would induce more severe down-regulation of Pax5 and Tcf1 in B cells and T cells, 
respectively. Enhancing glycolysis is achieved by retroviral overexpression of hexokinase 2 
(HK2), which is the rate-limiting enzyme in glycolysis (Roberts & Miyamoto, 2015), leading to 
an over-differentiation phenotype with more cells undergoing Pax5 and TCF1 repression (Figure 
4.2). In B cells, IRF4 was also upregulated when HK2 was overexpressed, suggesting that 






Figure 4.1 Suppression of aerobic glycolysis inhibits effector cell differentiation  
(A) Upper panel: Cell division versus Pax5 expression of CTV-labeled B cells stimulated 
with LPS for 3 days in absence or presence of mDivi-1 (10 μM) and increasing doses of  
2-Deoxy-D-glucose (2-DG) (0, 0.25, 0.50, and 0.75 mM left-to-right). In these B cell 
experiments, drug variables were added 18 hours after stimulation began. Lower panel: Cell 
division versus TCF1 expression of CTV-labeled P14 CD8+ T cells stimulated for 4 days with 
gp33-41 peptide plus IL-2 in the absence or presence of mDivi-1 and increasing doses of 2-DG 
(0, 0.5, 1.0, and 2.0 mM), present from the beginning of stimulation. (B) The statistical graph 
depicts frequency of Pax5lo B cells in indicated conditions (n=6, ***P<0.005, repeated measures 
one-way ANOVA).  (C) The statistical graph depicts frequency of TCF1lo CD8+ T cells in 








Figure 4.2 Enhancing aerobic glycolysis promotes eff ctor cell differentiation  
(A) CTV-labeled B cells stimulated for 36 hours with LPS prior to transduction with control or 
hexokinase-2 (HK-2) encoding retrovirus (RV) and analyzed 36 hours after transduction for cell 
division versus Pax5 and IRF4. Only transduced events are shown. Statistical graphs display 
frequency of Pax5lo and IRF4hi cells among cells transduced with control or HK-2 RV (n=3, 
*P<0.05, two-tailed paired t-test).  
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(B) CTV-labeled CD8+ T cells stimulated with anti-CD3 and anti-CD28 antibodies with IL-2 for 
36 hours prior to transduction with control RV or hexokinase 2 encoding RV and analyzed 36 
hours after transduction for cell division versus TCF1. Only transduced events are shown. 
Statistical graph depicts frequency of TCF1lo cells among cells transduced with control or HK-2 




4.2 Glycolysis regulates surface and intracellular glucose transporter level 
        Activated lymphocytes augment their glycolysis ability by increasing expression of HK2 
and glucose transporters (Sukumar et al., 2013). Among the 13 glucose transporter family 
members, Glut1 is the predominant glucose transporter expressed in activated CD8+ and CD4+ T 
cells (Macintyre et al., 2014) as wells as activated B cells (Caro-Maldonado et al., 2014). 
Conditionally knocking out Glut1 in B cells impairs B cell homeostasis and antibody production 
(Caro-Maldonado et al., 2014), whereas knockdown Glut1 in CD4+ T cells impairs proliferation, 
differentiation, and decreases survival. The result of knocking down Glut1 in CD8+ T cells is less 
obvious than that observed in CD4+ T cells, because CD8+ T cells are able to compensate for the 
lack of Glut1 by upregulating the expression of Glut3, which is normally downregulated after 
activation (Macintyre et al., 2014). 
Our recent publications provide evidence that treating activated lymphocytes with 2-DG 
reduces the levels of intracellular ROS (measured by DCFDA) and phosphorylated S6, which is 
an indication of mTORC1 activity. Therefore, we asked whether inhibiting glycolysis of 2-DG 
would affect glucose up-take. I performed intracellular staining with an anti-Glut1 antibody 
recognizing the intracellular domain in LPS stimulated B cells. The result demonstrated that the 
intracellular Glut1 level is strongly reduced by 2-DG in Pax5 low B cells (Figure 4.3 A). 
Moreover, 2-DG treatment also reduces the surface level of Flag-tagged Glut1 in transduced B 
cells (Figure 4.3 B), implying glucose deprivation may activate Glut1 transportation to the cell 
membrane. These results suggest an active glycolyti pa hway is required for maintaining the 
intracellular and surface protein levels of Glut1, and that glycolysis can feedback to regulate the 









Figure 4.3 Inhibiting glycolysis reduces intracellular Glut1 but upregulates surface Glut1  
(A) Glycolytic feedback regulates intracellular Glut1 levels 
B cells are stimulated with LPS for 48 hours, befor adding the drugs PI3K inhibitor LY294002 
(5uM) and 2-DG (0.5mM), and then analyzed by day 3.5 after stimulation (36 hours after 
introduction of the drug treatments). The experiment has been repeated two times. (B) B cells 
were activated with LPS for 40 hours before spin infection. Activated B cells were infected with 
retroviral vector expressing Flag-Tagged-Glut1/NGFR or control NGFR vector and then further 
cultured for 24 hours before FACS analysis. Drugs were added by 6 hours after spin infection. 
The FACS plot represents NGFR positive events.  
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4.3 Glut1 polarization in dividing lymphocytes results in differential inheritance of Glut1 
As discussed in an earlier section, we found that high membrane potential mitochondria 
are enriched in the daughter cell that acquires more Pax5. Live cell imaging using Cyto-ID, 
MitoTracker, and LysoTracker pulsed staining has provided evidence that the daughter cells 
have different abilities to remove old mitochondria. However, this result did not rule out another 
possibility: that that differential mitochondrial me brane potential may indicate the daughter 
cells have adopted different metabolic program. 
     To obtain biological macromolecules (such as DNA, polysaccharides, and proteins) for 
building new cells, proliferating cells need to uptake carbon and nitrogen from the environment. 
However, the cell membrane serves as a barrier to prevent nutrient molecules from diffusing in 
and out the cell. Most of the nutrient molecules (amino acids, peptides, fatty acids, and 
carbohydrates) pass through the cell membrane by way of  transporter complex. Our recent 
publications demonstrate that dividing lymphocytes are able to produce daughter cells with 
opposing cellular metabolisms, which is enabled by asymmetric expression/accumulation of 
metabolic regulators such as FoxO1 and IRF4. Given that 2-DG affects intracellular Glut1 levels, 
we want to know whether the daughters may inherit or express different amounts of nutrient 
transporters thus establishing and amplifying the diff rent metabolic programs in the daughter 
cells. In this study, I imaged the subcellular locaization of amino acid transporter heavy chain 
CD98 and the glucose transporter 1 (Glut1), respectively. 
     CD98, an early marker of T-cell activation, is a dual function protein. The protein is required 
to support rapid proliferation and lymphocyte clonal expansion by conducting extracellular 
integrin signals to cells to induce proliferation and to suppress apoptosis (Cantor, Slepak, Ege, 
Chang, & Ginsberg, 2011; Kurihara et al., 2015). It also serves as a subunit of the amino acid 
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transporter complex (Gottesdiener et al., 1988; Lindsten, June, Thompson, & Leiden, 1988). The 
uptake of branched-chain (valine, leucine, isoleucine) and aromatic (tryptophan, tyrosine) amino 
acids by lymphocytes is mediated by CD98 heterodimer, which served as the L-type amino acid 
transporter 1 (LAT1) (Kanai et al., 1998). The CD98 heterodimer is composed of a heavy chain 
(4F2 antigen heavy chain) with a type II single-pass transmembrane domain and one of the 
alternative multi-pass light chains. The CD98 heavy chain serves as an anchor to restrain the 
light chain on the cell membrane by disulfide linkage with the light chain (Nakamura et al., 
1999). 
    Knocking out the Slc3a2 gene, which encodes the heavy chain of CD98, blocks the 
proliferation of B cells and prevents their differentiation into plasma cells (Cantor et al., 2009). 
By contrast, knocking out Slc3a2 in T cells results in a reduced proliferation rate induced by 
plate bound antigens (anti-CD3 plus anti-CD28 Abs in the presence of IL-2) and modestly 
impaired homeostatic proliferation (Cantor et al., 2011). KN Pollizzi et. al. reported that when 
CD8+ T cells are activated by antigen-presenting cells, the differential expression of CD98 in the 
cytokinetic stage contributes to asymmetric mTORC1 activity in daughter cells (Pollizzi et al., 
2016). 
      To test whether asymmetric CD98 is associated with the observed asymmetric Pax5 in 
dividing B cells and Tcf1 in dividing T cells, I performed an immunofluorescence assay to trace 
the dynamics of CD98 in different cell cycle stages in B cells and T cells. The B cells were 
stimulated with LPS in vitro, whereas CD8+ T cells derived from P14 transgenic mice were 
stimulated with gp33 peptide, because CD98 polarity has been reported to rely on antigen-
presenting cell-mediated activation. In both LPS-stimulated B cells and gp33-activated P14 
CD8+ T cells, all of the CD98 staining is restricted to the cell membrane, and remains on the cell 
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surface through interphase, metaphase, and telophase (Figure 4.4). There is no evidence of CD98 
polarization in metaphase or telophase cells. 
On the other hand, we found that Glut1 staining waspuncta or vesicle-like and localized to 
the microtubule-organizing center (MTOC) in interphase B cells and CD8+ T cells. The most 
significant difference between the patterns of CD98 and Glut1 is that Glut1 is polarized to one of 
the MTOC in pro-metaphase cells, and such polarity can be also found in metaphase cells. We 
also find that in LPS-stimulated B cells and P14 CD8+ T cells, telophase cells have acquired 
different amount of Glut1 (Figure 4.5). To demonstrate that the observation was not an artifact or 
staining problem, I used retroviruses expressing Glut1-GFP fusion protein and mCherry-tubulin 
to perform live cell imaging in LPS-stimulated B cells. We have obtained videos to validate that 
the GFP-containing intracellular vesicle was co-loca ized with the MTOC in the interphase cells 
(Figure 4.5, the cell on the left), and that a large GFP-positive vesicle containing Glut1 is 









Figure 4.4 CD98 is not polarized in dividing B cells and CD8+ T cells 
(A) LPS-stimulated B cells are sorted for immunoflurescence staining by day 3.5 after 
stimulation. This plot shows representative events for interphase (n=2), metaphase (n=2) and 
telophase (n=6), respectively.  
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(B) Splenocytes derived from P14 transgenic mice were stimulated with gp33 peptide and IL-2 
for 3.5 days. Enlarged splenocytes were sorted for immunofluorescence staining. This plot shows 
representative events for interphase (n=4), pro-metaphase (n=1) and metaphase (n=2), 







Figure 4.5 Glut1 is polarized in LPS-stimulated B cells and P14 CD8+ T cells 
(A) LPS (20ug/ml)-stimulated B cells were sorted for immunofluorescence staining by day 3 
after stimulation. The B cells were fixed with 3% PFA in PBS, and then permeabilized with 
0.3% Triton X100. After blocking, the samples were stained with rabbit monoclonal antibody to 
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Glut1 (EPR3915) and goat-anti-rabbit IgG Alexa Fluor® 568 dye. This plot shows representative 
events for interphase (n=2), metaphase (n=5), and telophase (n=9), respectively. (B) Thy 1.1+ 
P14+ CD8+ T cells were transferred into a Thy 1.2+ recipient animal, and then the recipient 
animal was infected with 5 × 103 PFUs of Listeria monocytogenes expressing gp33-41 (LMgp33) 
by i.v. injection. By 4 days after infection, enlarged, CD8+, Thy 1.2- cells were sorted for 
immunofluorescence analysis. This plot shows representative events for interphase (n=2), 





Figure 4.6 Live cell imaging reveals sibling cells inherit unequal amounts of Glut1 during 
cytokinesis 
A representative time-lapse series of LPS-stimulated B cells (day 3) transduced with retrovirus 
expressing either mCherry-alpha-tubulin or Flag-tag-Glut1-GFP fusion protein 16 hours prior to 
imaging by spinning disk confocal microscopy. Frames, l ft-to-right, represent 3-minute 
intervals. Scale bars are 7 µm. The cell on the left is an interphase cell, whereas the cell on the 




4.4 Glut1 proteins are stored in intracellular vesicles 
The asymmetric Glut1 level in daughter cells, prompted us to find out more details about 
the localization of Glut1 and the biological significance of Glut1 levels. Using retrovirus 
expressing Flag-tagged rat Glut1, we were able to stain urface Glut1 (by anti-Flag antibody) and 
intracellular Glut1 (by anti-Glut1 C-terminal antibody). The results showed that in interphase B 
cells, Glut1 was located in intracellular structures, whereas there was only some spot-like surface 
Flag-tagged Glut1 staining (Figure 4.7). Also, I found that the amount of surface Flag-tagged 
Glut1 in interphase cells was much higher than in metaphase cells and telophase cells (Figure 
4.7). Although the staining of surface Flag-tagged Glut1 is lower than intracellular Glut1, the 
staining patterns of Glut1 and surface Flag-tagged Glut1 are very similar, suggesting there is a 






Figure 4.7 Immunofluorescence analysis of surface Glut1 and intracellular Glut1 
B cells were stimulated with LPS (20ug/ml) for 40 hours before spin infection with retrovirus 
expressing Flag-tagged rat-Glut1 and truncated human NGFR. After being cultured for another 
24 hours, the transduced cells were sorted by FACS for NGFR positivity and then subjected to 




4.5 Upregulation of intracellular and surface Glut1 marks effector cell differentiation 
Intracellular Glut1 staining demonstrated that the B cells which upregulated Glut1 were a 
heterogeneous population comprised of Pax5 high and P x5 low cells, whereas the Glut1 low 
cells were enriched for Pax5 high cells, which suggests that increasing intracellular Glut1 may be 
associated with effector cell differentiation (Figure 4.8). We also performed confocal imaging on 
LPS-activated B cells and anti-CD3-, anti-CD28-, and IL- 2-stimulated CD8+ T cells infected 
with Flag-tagged Glut1 retrovirus. Co-staining Flag-t ged Glut1 and Pax5 or Tcf1 in B cells 
and CD8+ T cells, respectively, revealed that Pax5 high B cells exhibit low Glut, and that Tcf1 
low CD8+ T cells had a higher level of Glut1. Moreover, endosomal Glut1 could be found in 
Pax5 low B cells and Tcf1 low CD8+ T cells (Figure 4.9). 
Because confocal imaging has shown that surface Glut1 is localized near intracellular Glut1 
vesicles, we tested whether surface Glut1 levels marked differentiation of effector cells. By using 
B cells and CD8+ T cells derived from Myc-tagged Glut1 mice, we found that those cells which 
upregulate surface Glut1 have a greater probability of being identified as Pax5 low B cells or 
Tcf1 low CD8+ T cells, suggesting that upregulated surface Glut1 may mark populations that 
exhibit a bias to differentiate into effector cells (Figure 4.10). 
To further test whether in vivo activated T cells ao upregulated Glut1 when differentiating 
into effector cells, we immunized mice expressing Myc-Tag-Glut1 with LCMV Armstrong strain, 
which is an acute infection model. At day 7 post-infection, animals were sacrificed for analysis 
of splenic CD8+ T cells by flow cytometry. After been activated by antigen, CD8+ T cells 
upregulated CD44 and a subset of the CD44 positive population further upregulated KLRG1 and 
downregulated Tcf1 to become effector T cells (W. W. Lin et al., 2016). Surface Myc-tag-Glut1 
staining revealed that Tcf1 low, but not Tcf1 high, CD8+ T cells upregulated surface Glut1 
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together with surface CD44 (Figure 4.11 A). In addition, in wild-type B6 mice infected with 
LCMV, we found that the intracellular Glut1 level was also positively correlated with the surface 
CD44 level, but not the KLRG1 level. Taken together, these data reveal that in vivo-stimulated 
CD8 T cells upregulated intracellular and surface Glut1 when they downregulated Tcf1, but 






Figurer 4.8 Intracellular Glut1 and Pax5 levels in B cells 
B cells were activated with LPS (20ug/ml) for 3 days before FACS analysis. 
Samples were stained with green live/dead dye before being fixed and permeabilized with 
Foxp3/Transcription Factor Staining Buffer Set (eBioscience). After permeabilization, samples 
were stained with rabbit monoclonal antibody [EPR3915] to Glucose Transporter GLUT1 
(Abcam), rat anti-Pax5 [1H9]-PerCP/Cy5.5 (BioLegend), and rat anti-IRF4 PE (eBioscience), 
and then with goat-anti-rabbit IgG conjugated to Alexa Fluor® 647 dye. Experiment has been 





Figure 4.9 Effector cells exhibit higher Glut1 levels 
  B cells were activated with LPS (20ug/ml) for 40 hours before being infected with retrovirus 
expressing Flag-tagged Glut1 and truncated human NGFR. Similarly, CD8+ T cells were 
stimulated by anti-CD3, anti-CD28 and IL-2 (100units/ml) for 40 hours and then infected with 
retrovirus expressing Flag-tagged Glut1 and truncated human NGFR. At 26 hours after retroviral 
infection, NGFR-positive B cells or CD8+ T cells were sorted by flow cytometry for 
immunofluorescence staining. Flag-tagged Glut1 was st ined with rat anti-DYKDDDDK-tag 









Figure 4.10 Upregulation of surface Glut1 marks effector cell differentiation 
(A) B cells enriched from spleens of homozygous Myc-Tagged-Glut1 transgenic mice were 
stimulated with LPS (20ug/ml) for 3 days. The cells were stained with Red live/dead dye, and 
rabbit c-Myc antibody [71D10], and then goat anti-rabbit IgG conjugated to Alexa Fluor® 
647 dye before fixation and permeabilization for int acellular anti-Pax5-PE staining. 
(B) CD8+ T cells enriched from spleens of homozygous Myc-Tagged-Glut1 transgenic mice 
were stimulated by plate-bound anti-CD3 and anti-CD28 antibody as well as IL-2 (100 units/ml) 
for 3 days. The samples were stained with Green live/dead dye, and mouse Myc Tag antibody 
[4A6], and then goat anti-Mouse IgG conjugated to Alexa Fluor® 647 dye before fixation and 








Figure 4.11 Surface Glut1 is upregulated in effector T cells in acute LMCV infection 
     Mice were infected with the Armstrong strain of LCMV (2*105 PFU) by intraperitoneal 
injection. The animals were sacrificed by day 7 post-infection. The experiments have been 
repeated twice. (A) In Myc-Tagged Glut1 transgenic m e (n=4), Tcf1 low CD8+ T cells 
upregulate surface Glut1 during activation. The surface level of Glut1 increased when CD44 was 
upregulated. (B) Wild-type mice infected with LCMV for 7 days. The intracellular Glut1 




4.6 The PI3K/mTORC1 pathway maintains intracellular and surface Glut1 levels 
Three classes of PI3Ks generate different pools of the lipid second messenger, 
phosphoinositides 3 phosphates, on plasma membranes, endosomes, autophagosomes, and 
multivesicular bodies (MVBs) (Marat & Haucke, 2016). Class I PI3Ks produce predominately 
phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). The assembly of the catalytic and 
regulatory subunits of Class I PI3Ks on membranes is directed by activated guanine nucleotide-
binding protein coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs) (Jean & Kiger, 
2014). PI(3,4,5)P3 provides the docking sites for the pleckstrin homology (PH) domain of AKT, 
which then signals through mTOCRC1 and Foxo1 (Thomas, Deak, Alessi, & van Aalten, 2002; 
Tzivion, Dobson, & Ramakrishnan, 2011). Insulin stimulation has been reported to increase 
Glut1 protein content in 3T3-L1 adipocytes. This phenomenon occurs because the 
PI3K/PKB/mTOR cascade increases the transcription and translation of Glut1 mRNA (Taha et 
al., 1999).  
      To validate whether PI3K also regulates the total Glut1 protein level in B cells and CD8+ T 
cells, we measured the intracellular Glut1 level by FACS after treatment with different inhibitors, 
including LY294002, a pan-PI3K inhibitor that targets PI3K class I, PI3K class III, and a subset 
of other PI3K-related kinases (such as mTOR and DNA-PK) (Gharbi et al., 2007); ZSTK474, a 
class I PI3K-specific inhibitor (Kong & Yamori, 201); and rapamycin. We found that 
LY294002, ZSTK474, and rapamycin all exhibited a strong repression effect on intracellular 
Glut1 levels in both in vitro activated B cells and CD8+ T cells, suggesting that the class I PI3K 
and mTORC1 pathway regulate the biogenesis and stability of Glut1 protein (Figure 4.12). 
      In addition to measuring the total intracellular Glut1 level, we also asked whether the PI3K 
pathway regulates the surface level of Glut1 protein. We measure the surface level of Glut1 by 
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using activated lymphocytes with retrovirus incorporating exofacial Flag-tagged rat Glut1 or 
lymphocytes derived from transgenic mice carrying Myc-Tagged–Glut1 alleles (Wardell et al., 
2009; Wieman et al., 2007). The results of both assays indicated that suppressing pan-PI3K 
activities by LY294002, inhibiting class I PI3K, and inhibiting mTOCR1 all lead to the reduction 
of the surface Glut1 protein level (Figure 4.13, 4.14)  Therefore, class I PI3K may act by 
stimulating the targeting of Glut1 to the plasma membrane, or may be required for intracellular 







Figure 4.12 Class I PI3K and mTOCR1 regulate intracellular Glut1 levels 
(Left) B cells were stimulated by LPS (20ug/ml) for2.5 days before the addition of drugs and 
then harvested for FACS analysis 36 hours after the addition of the drugs. (Right) CD8+ T cells 
derived from homozygous Myc-tagged Glut1 transgenic mice were stimulated with anti-CD3, 
anti-CD28, and IL-2 (100 units/ml). Drugs were adde 2.5 days after activation, and then the 






Figure 4.13 Class I PI3K and mTOCR1 regulate surface Glut1 levels 
(Left) B cells were activated with LPS (20ug/ml) for 40 hours before infection with retrovirus 
carrying either Flag-tagged rat Glut1 IRES truncated human NGFR (tNGFR) or pMIG IRES 
tNGFR empty vector. Drugs were added 8 hours after spin infection. Infected cells were 
incubated with the drugs at indicated concentration for 18 hours before being harvested for 
FACS analysis.  
(Right) CD8+ T cells derived from wild-type B6 mice were stimulated with anti-CD3, anti-CD28, 
and IL-2 (100 units/ml) for 40 hours before spin infection. Activated CD8+ T cells were 
transduced with retrovirus carrying either Flag-tagged rat Glut1 IRES tNGFR or pMIG IRES 
tNGFR empty vector. Drugs were added 8 hours after transduction and then the cells were 






Figure 4.14 Class I PI3K and mTOCR1 regulate surface Myc-tagged Glut1 levels 
(Left) B cells derived from homozygous Myc-tagged Glut1 transgenic mice were stimulated with 
LPS for 2 days before drug was added. After drug addition, the B cells were further cultured for 
18 hours before FACS analysis with Rabbit Myc-Tag antibody and Goat-anti-Rabbit IgG 
conjugated to Alexa Fluor® 647 dye. 
(Right) CD8+ T cells derived from homozygous Myc-tagged Glut1 transgenic mice were 
stimulated with anti-CD3, anti-CD28, and IL-2 (100 units/ml). Drugs were added 2.5 days after 
activation, and cells were then cultured for additional 18 hours before being harvested for FACS 





4.7 Inhibition of PI3K abolishes Glut1 polarity in dividing lymphocytes 
To understand the effect of PI3K on Glut1 localization, we performed immunofluorescence 
staining to compare the localization of Glut1 in different stages of cell division. We found that 
PI3K inhibitor LY294002-treated B cells lost polarization of Glut1 vesicles to the MTOC in 
prophase (the two MTOCs were not positioned on the opposite sides of the dividing cells, and 
the chromatin has not yet condensed,) and metaphase (MTOC were positioned on the opposite 
sides of the dividing cells, and the chromatin has condensed and lined up in the center of the 
cell) (Figure 4.15). Moreover, PI3K inhibitor LY294002 abolished the asymmetric Glut1 
phenotype in cytokinetic cells. In the presence of PI3K inhibitor, Glut1 vesicles are equally 
distributed into the two daughter cells, suggesting hat the polarization of Glut1 in prophase and 
metaphase requires PI3K to establish polarization signals. Notably, in all of the images, PI3K-
treated cells exhibit lower Glut1 staining, which is in consistent with the our FACS data, in 






Figure 4.15 PI3K inhibitor abolishes asymmetric Glut1 localization 
B cells derived from wild-type B6 mice were stimulated with LPS (20ug/ml) for 3 days before 
being sorted for immunofluorescence staining. PI3K inhibitor LY294002 (5uM) was added 




4.8 Rab11a regulates surface and intracellular Glut1 levels and is required for polarization 
and asymmetric segregation of Glut1 vesicles in dividing cells 
The PI3K signaling pathway has been shown to enhance surface Glut1 levels in response to 
IL-3 stimulation through a Rab11a-mediated pathway in the murine prolymphocytic cell line 
FL5.12 (Wieman et al., 2007). To validate whether tis pathway is also responsible for the 
trafficking of Glut1 in mature lymphocytes, we infect d CD8+ T cells derived from Myc-tagged 
Glut1 mice with retrovirus expressing wild-type or dominant negative Rab11a (S25N) fused to 
GFP to measure the surface Glut1 level with Myc-Tag antibody and the intracellular Glut1 
protein level by anti-mouse Glut1 antibody. The results showed that expression of dominant 
negative Rab11a increased the intracellular Glut1 level at the expense of reducing the surface 
Glut1 level, suggesting that abolishing the GTPase activity of Rab11a (the GDP-locked form) led 
to the accumulation of intracellular Glut1 and reduced the recycling of Glut1 back to the plasma 
membrane (Figure 4.16) . This result is comparable to what has been reported in the IL-3 
prolymphocytic cell line FL5.12. 
       In addition to Glut1 levels, we also measured the effect of expressing dominant negative 
Rab11a on the transcriptional program during lymphocyte proliferation and differentiation. 
Retrovirus expressing dominant negative Rab11a suppressed Pax5 but upregulated IRF4 in LPS-
stimulated B cells (Figure 4.17 A). Similarly, overexpression of dominant-negative Rab11a 
suppressed Tcf1 in in vitro activated CD8+ T cells (Figure 4.17 B). Thus, overexpressing 
dominant negative Rab11a promotes effector cell differentiation. 
      Finally, we performed confocal analysis to determine the effect of over-expression of 
dominant negative Rab11a on the localization of Glut1 vesicles in dividing lymphocytes. 
In B cells, overexpression of GFP-wild type Rab11a increased the amount of intracellular Glut1 
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vesicles. Although some the vesicles are not located near MTOC, most Glut1 vesicles were still 
polarized to the MTOC in interphase and metaphase. Al o, daughter cells exhibiting asymmetric 
amounts of Glut1 could be found in 50% of the cytokinetic pairs. By contrast, overexpression of 
GFP-dominant negative Rab11a increased the amount of intracellular Glut1 vesicles, but these 
vesicles were not co-localized with the MTOC, and their distribution was more diffuse in the 
metaphase cells. In almost all of the observed cytokinetic cells, both daughter cells inherited 
equal amounts of Glut1, suggesting that asymmetric Glut1 distribution and polarization to the 
MOTC are both dependent on a Rab11a-mediated pathway (Figure 4.18). This loss of polarity 
and asymmetric Glut1 phenotype is similar to the observation in PI3K inhibitor Ly294002-
treated cells, implying the PI3K/mTORC1 pathway may provide polarized signals for Glut1 





Figure 4.16 Rab11a regulates surface and intracelluar Glut1 levels 
CD8+ T cells were enriched from the spleen of homozygous Myc-tagged Glut1 ansgenictr mice 
and stimulated for 40 hours by plate-bound anti-CD3, anti-CD28, and IL-2 (100 units/ml) in the 
media. Activated cells were infected with retrovirus carrying GFP-wild-type Rab11a, GFP-
dominant negative Rab11a (S25N), or GFP-expressing co trol vector (MIGR1) and cultured 
with plate-bound anti-CD3, anti-CD28, and IL-2 in the media for 18 hours before FACS analysis. 
The surface Myc-tagged Glut1 was stained by Mouse Myc-Tag antibody (Clone 4A6) with Goat 
anti-mouse IgG conjugated to Alexa Fluor® 647 dye, whereas the intracellular Glut1 was 
detected by rabbit monoclonal [EPR3915] antibody to Glucose Transporter GLUT1 with Goat 






Figure 4.17 Dominant-negative Rab11a induced effector cell differentiation  
B cells were stimulated by LPS (20ug/ml) and CD8+ T cells were stimulated by plate bound anti-
CD3 and anti-CD28 with IL-2 (100units/ml) in the media for 40 hours before retroviral 
transduction. Activated cells were transduced with MIGR1 (GFP control), GFP-Wild-type 
Rab11a, or GFP-dominant negative Rab11a. The expression of dominant-negative Rab11a 





Figure 4.18 Overexpression of dominant-negative Rab11a abolishes the Glut1 asymmetric 
phenotype in dividing lymphocytes 
B cells were activated with LPS for 40 hours before spin infection with retrovirus carrying  
GFP-Rab11a WT, GFP Rab11a-dominant negative, or MIGR1 (GFP control). The GFP-positive 
cells were sorted by day 3 after activation. This cart shows confocal image analysis of Glut1 
protein staining in representative interphase (WT: n=9, DN: n=5), metaphase (WT: n=21, DN: 





4.9 Lis1 regulates the polarization of Glut1-containing intracellular vesicles toward MTOC 
By using CD4-Cre to conditionally delete Lis1 in CD4+ and CD8+ T cells, we found that P14+ 
Lis1f/f CD4-Cre CD8+ T cells divided relatively slower compared to P14+ Lis1f/f CD8+ T cells 
when stimulated by gp33 and IL-2. The Lis1f/f CD4-Cre CD8+ T cells also showed relatively 
lower Tcf1 repression compared to Lis1f/f siblings (Figure 4.19).  
        Confocal analysis revealed that most of the cultured P14+ CD8+ T cells derived from the 
Lis1f/f CD4-Cre animal lack intracellular vesicles containing Glut1, but these T cells still have 
strong Glut1 staining near the cell membrane, suggesting knocking out Lis1 mainly affects 
recycling endosome but not surface Glut1 (Figure 4.20). In some of the interphase cells with 
intracellular Glut1 vesicles, these vesicles are not polarized toward the MTOC, which is similar 
to the phenotype of PI3K inhibitor-treated CD8+ T cells. This result also confirms that the 
formation of large Glut1 vesicles near MTOC requires motor protein and vesicle transportation 
and therefore the large GFP-positive vesicles observed in live cell imaging of Glut1-GFP are not 






Figure 4.19 Knocking out Lis1 affects effector cell differentiation  
The splenocytes derived from Lis1f/f, CD4-Cre+, P14+ and Lis f/f, Cre negative, P14+ animals 
were labeled with CellTraceTM Violet proliferation dye and then activated by gp33 (1ug/ml) and 
IL-2 (100 units/ml). Activated cells were harvested for analysis after being cultured for 80 hours. 
(Upper) FACS analysis of Tcf1 repression in Lis1 KOcells (Lis1f/f, CD4-Cre+) and control cells 
(Cre-negative). Y-axis represents the Tcf1 staining, whereas the X-axis shows the cell 
proliferation dye staining (CellTraceTM Violet). 
(Lower Left): A histogram comparing the Tcf1 level in Lis1 KO cells and control cells. 






Figure 4.20 Lis1 is required for Glut1 vesicles to polarize to the MTOC 
The splenocytes derived from Lis1f/f, CD4-Cre+, P14+ (Lis1 KO) and Lisf/f, Cre negative, 
P14+ (WT) animals were activated by gp33 (1ug/ml) and IL-2 (100 units/ml). Activated cells 
were harvested for analysis after 3 days of culture. (L ft) Representative interphase cells in Lis1 
KO and WT animals. (Right) The bar chart compares th  frequency of cells positive for Glut1 
staining (upper), and the percentage of cells with Glut1 vesicles polarized to the MTOC. The 




Chapter 5: Discussion 
5.1 Is remodeling mitochondrial fusion and fission sufficient to alter effector and memory 
cell differentiation?  
In a recent paper, Pearce and her colleagues proposed a model suggesting that enforcing 
mitocohondrial fission in effector cells reprogrammed their metabolism and imposed a memory 
cell phenotype(Buck et al., 2016). The authors stated that perturbing the fission and fusion of 
mitochondria is sufficient to reprogram the metabolism of effector cells and that mitochondrial 
morphology is a determining factor in T cell fate. Their data showed that the formation of a 
memory cell-like population was enhanced by adding mDivi-1 (10uM) to the culture media by 
day 3. However, our data indicate that treating cells with Mdivi-1 from the beginning of the 
culture accelerates the downregulation of Tcf1, implying that suppressing mitochondrial fission 
promotes effector cell differentation. At the first glance, these results are in conflict with each 
other. However, our experiment reveals that the effici ncy of mDdivi-1 mediated repression of 
Pax5 or Tcf1 is dependent on the time point with which it is added to the culture. When Mdivi-1 
or CCCP is added to the stimulated B cells or T cells within the first 36 hours after stimulation, 
the downregulation of Tcf1 in T cells and of Pax5 in B cells, respectively, is accelerated. The 
repression effect is less obvious when Mdivi-1 or CCCP is added 48 hours after stimulation. This 
data suggests that two important determinants for the effect of inhibiting mitochondrial fission 
are the number of divisions the cultured cells have undergone before drug treatment and the 
incubation time of the cultured cells with the drug. 
     We explained that Mdivi-1 did not cause acute damage to mitochondria with short-term 
treatment, but in the long-term, inhibition of the mitochondrial fission mechanism leads to 
accumulation of damaged mitochondrial compartments. Clearly, whereas fusion of relatively 
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healthy mitochondria may increase metabolic functio, fusion of damaged mitochondria will not 
prevent the further accumulation of damage. Thus, we believe that the Pearce model which states 
that "fission favors effector and fusion favors memory" is oversimplified. The coordinated 





5.2 Do AMPK and mTORC1 work cooperatively in rapidly proliferating lymphocytes? 
It is well known that AMPK and mTORC1 are activated under opposite nutrient conditions. 
AMPK is activated under nutrient-deficient conditions, whereas mTORC1 is activated under 
nutrient-high conditions. Moreover, AMPK suppresses mTORC1 by phosphorylating Raptor and 
other mTORC1 associated proteins, such as TSC2 (Gwinn et al., 2008; Inoki et al., 2006). 
However, we found that even in normal culture conditions, B cells or T cells derived from an 
AMPK knockout animal exhibit a tendency for early downregulation of Pax5 or Tcf1, 
respectively, compared with B cells or T cells deriv d from wild-type animals. It is unlikely that 
this phenomenon is due to the cells running out of available nutrients after 4 days in culture, 
because the AMPK knockout cells start to downregulate Pax5 or Tcf1 after the first 2 divisions. 
These data suggest that even in the presence of sufficient nutrients and growth factors, rapidly 
proliferating cells may gradually subject to cellular stress responses. The stress may come from 
misfolding protein response of the endoplasmic reticulum and enhancing ROS generation during 
ATP production. 
 
5.3 The linkage between PI3K and Glut1 trafficking 
    The detailed mechanism of how PI3K maintains intracellular and surface Glut1 protein levels 
remains unclear. Most of the earlier studies use LY294002 as a reversible PI3K inhibitor 
(Doughty et al., 2006; Wieman et al., 2007). Unfortunately, LY294002 has been found to inhibit 
several PI3Ks, including the PI3K p110 gamma isoform, and even other protein kinases (Gharbi 
et al., 2007). Therefore, we cannot rule out the possibility that the observed Glut1 alteration after 
LY294002 treatment is due to protein kinases other t an PI3Ks. Also, LY294002 cannot 
selectively inhibit different PI3K isoforms; and thus more elegant experiments combining 
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inducible and conditional gene targeting should be performed to confirm which PI3K subunits 
are responsible for Glut1 trafficking, membrane docking, and degradation. Finally, LY294002 
could also inhibit the effect of mTORC1 and therefo we cannot determine whether its effect 
was directly mediated by inhibition of PI3Ks or was through its off-target effect on mTORC1 
(Brunn et al., 1996). 
     One of the potential links between PI3K and Glut1 trafficking may be WNK1. 
WNK1 is a protein kinase that regulates the Tre-2/USP6-BUB2-Cdc16 Domain Family Member 
4 (TBC1D4)-Rab8A Complex, which is required for translocation of Glut1 to the surface of cell 
membranes (Mendes, Matos, Moniz, & Jordan, 2010). WNK1 can be phosphorylated on Thr60. 
In 3T3-L1 cells, insulin-like growth factor I-stimulated WNK1 phosphorylation could be blocked 
by the irreversible PI3K inhibitor wortmannin and RNA interference-directed depletion of Akt1 
and Akt2, but not by rapamycin (Jiang et al., 2005). These results suggest the involvement of the 
PI3K/AKT pathway in WNK1 phosphorylation, but not mTORC1. 
      Interestingly, a recent study demonstrated th role of WNK1 in T cells to promote cell 
migration but to attenuate integrin-mediated adhesion. We are looking forward to testing whether 
targeting WNK1 would induce lost polarity of Glut1 in dividing B and T cells, just as in 
LY294002 treated cells. If so, the result will support a model that PI3K/AKT regulate WNK1-





5.4 PI3K, AKT, mTORC1, and Glut1 surface expression 
      A further question about how PI3K regulates Glut1 surface expression is whether AKT and 
mTOCR1 are also involved in optimizing the trafficking of Glut1. The first paper which 
described that inhibiting PI3K activity blocks Glut1 surface expression in B cells was published 
in 2006 (Doughty et al., 2006). The authors demonstrated that the abundance of Glut1 protein in 
splenic B cells activated by F(ab’)2 fragments of anti-mouse IgM is reduced by treatment with 
PI3K inhibitor LY294002 and deletion of p85α, a key subunit of PI3K, suggesting that the PI3K 
pathway is contributing to regulating the expression of Glut1. This paper also noted that the total 
Glut1 protein level in these anti-IgM activated wild-type B cells was not affected by rapamycin 
treatment. 
      The next year, J C Rathmell and his colleagues published a paper using the early 
hematopoietic myeloid/lymphoid cell line FL5.12 expressing exofacial-FLAG epitope tagged rat 
Glut1 to study the effect of altering PI3K and AKT activity on the surface expression of Glut1 
(Wieman et al., 2007). The result of a pulse-chase assay showed that removing cytokine IL-3 
from the media accelerated the turnover rate of labeled surface Glut1. Moreover, treatment with 
the PI3K inhibitor LY294002 blocked the IL-3 induced Glut1 surface expression, but did not 
affect the total protein level of FLAG-Glut1. Expressing myristoylated and constitutively active 
Akt (myrAkt) or phospho-mimetic (S473D/T308D; AktDD) forms of Akt1 is sufficient to 
maintain the surface FLAG-Glut1 level in the presence and absence of IL-3. Overexpressing 
myrAkt enhanced surface FLAG-Glut1 expression. Such phenotype could not be reverted by 
treatment with rapamycin, suggesting that it is the activity of AKT, but not mTORC1, that is 
responsible for modulating surface Glut1 trafficking. One of the caveats of this study is that they 
did not use wild-type lymphocytes and could not rule out the effect of rapamycin on the 
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efficiency of transient transfection of myrAkt. 
 
5.5 The dynamics and localization of Glut1 vesicles 
     Our live cell imaging and immunofluorescence staining have demonstrated that Glut1-
containing vesicles are polarized in dividing lymphocytes. The surface level of Glut1 is regulated 
by endocytosis and endocytic recycling. After endocyt sis, cargo proteins can be transported 
through a series of endosome compartments. The major compartments are early endosomes, late 
endosomes, and the endocytic recycling compartment (ERC) and recycling endosomes (Grant & 
Donaldson, 2009). Early endosomes are coated with Rab5 and early endosome antigen 1 (EEA1), 
whereas recycling endosomes are marked by Rab11a. Late endosomes can be stained with 
LysoTracker, which is a dye that stains acidified vsicular structures in live cells. 
Live cell imaging using B cells infected with retrovirus expressing Glut1-mCherry fusion 
proteins and GFP-Rab11a fusion proteins reveals that part of the Glut1 vesicles are co-localized 
with GFP-Rab11a, suggesting a subset of the Glut1 vesicles are in the recycling endosomes. 
Further experiments are needed to identify what kind of endosome is asymmetrically segregated 





5.6 New evidence of asymmetric cell division on regulating self-renewal versus effector cell 
differentiation  
      Traditionally, the primary role of asymmetric cell division in mature lymphocytes was 
understood to be in the first cell division, when lymphocytes are activated by antigen-presenting 
cells (Oliaro et al., 2010). Also, the driver of diferent fates of the sibling cells was thought to be 
the asymmetric abundance of transcription factors, such as T-bet and Tcf1 in T cells, or Bcl6, 
Pax5, and IRF4 in B cells (Barnett et al., 2012; J. T. Chang et al., 2011; W. W. Lin et al., 2016; 
Nish et al., 2016). However, in recent years, several studies and our work have suggested that 
signals regulating metabolism and nutrient sensing also exhibit differences between the sibling 
daughter cells and these asymmetric phenotypes are not limited to the first cell division. Such 
signals include PI3K and mTOCR1 signaling, resulting asymmetric Foxo1 activity, 
phosphorylated-S6 abundance, and c-Myc protein level (W. H. Lin et al., 2015; Pollizzi et al., 
2016). 
        In this study, I further identify two mechanisms that contribute to establishing the 
differential fates of the sibling cells: asymmetry of mitochondrial stasis and glucose transporter. 
Both asymmetric phenotypes can be observed in the abs nce of antigen-presenting cells, 
suggesting these mechanisms can establish cell-intrinsic polarity cues. My experiments show that 
metabolism, mitochondria, and transcriptional programming interplay with each other to amplify 
the differences between the sibling cells. Thus, asymmetric cell division and cell differentiation 
are continuous and progressively changing processes.  
     Once the self-amplifying signals pass through a t reshold, the cells enter a transition point, 
where further stimulation will generate siblings with distinct transcriptional programs. Some of 
the sibling cells will lose self-renewal ability, leading to irreversible effector cell differentiation, 
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whereas the other cells maintain self-renewal ability and differentiation potential. Therefore, a 
clone can be used, but not lost, to generate daughter cells with diverse functions. 
We found that effector cells generate more ROS compared to self-renewing cells because they 
have a lower ability to renew aged mitochondria and higher capacity for aerobic glycolysis. 
Therefore, my studies also provide methods to control the direction of effector cell 
differentiation. Treatment with ROS scavengers and glycolysis inhibitors during cell division can 
suppress the downregulation of lineage-maintaining transcription factors. This technique would 
be helpful in developing better methods for making memory-like lymphocytes for immune 
therapies, in identifying methods for preventing exhaustion of activated lymphocytes in a cancer 
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